Integrated Filing — IndAS



General information about company

Scrip Code 524804
NSE Symbol AUROPHARMA
MSEI Symbol NOTLISTED
ISIN INE406A01037
Name of company AUROBINDO PHARMA LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2026
Date of end of financial year 31-03-2027
Date of board meeting when results were approved 04-11-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 26-10-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Second quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Unaudited
Segment Reporting Single segment
Description of single segment Pharmaceutical products
Start date and time of board meeting 04-11-2026   16:15:00
End date and time of board meeting 04-11-2026   18:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 09-02-2026
Indicate Company website link for updated RPT policy of the Company https://www.aurobindo.com/api/uploads/disclosure_under_regulation/RPT-Policy-Feb2026.pdf
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
No Default



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 3,17,733.00 5,97,684.00
Other income 10,280.00 34,469.00
Total income 3,28,013.00 6,32,153.00
2 Expenses
(a) Cost of materials consumed 1,38,097.00 2,66,986.00
(b) Purchases of stock-in-trade 135.00 135.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 7,772.00 2,967.00
(d) Employee benefit expense 30,007.00 59,598.00
(e) Finance costs 4,809.00 9,516.00
(f) Depreciation, depletion and amortisation expense 6,952.00 13,851.00
(f) Other Expenses
1 Other expenses 43,146.00 81,197.00
Total other expenses 43,146.00 81,197.00
Total expenses 2,30,918.00 4,34,250.00
3 Total profit before exceptional items and tax 97,095.00 1,97,903.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 97,095.00 1,97,903.00
6 Tax expense
7 Current tax 24,774.00 51,924.00
8 Deferred tax (37.00) (101.00)
9 Total tax expenses 24,737.00 51,823.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 72,358.00 1,46,080.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 72,358.00 1,46,080.00
17 Other comprehensive income net of taxes 132.00 159.00
18 Total Comprehensive Income for the period 72,490.00 1,46,239.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 5,754.00 5,754.00
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 12.58 25.33
Diluted earnings (loss) per share from continuing operations 12.58 25.33
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 12.58 25.33
Diluted earnings (loss) per share from continuing and discontinued operations 12.58 25.33
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes: 1.The above unaudited standalone financial results of Aurobindo Pharma Limited (the Company) has been prepared in accordance with the Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013 (the Act), read with the relevant rules issued thereunder and other accounting principles generally accepted in India and in terms of Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. 2. The above unaudited standalone financial results of the Company as reviewed by the Audit Committee have been approved by the Board of Directors at its meeting held on November 04, 2026. The results for the quarter and half year ended September 30, 2026 has been reviewed by our statutory auditors. The statutory auditors of the Company have issued an unmodified conclusion in respect of the limited review for the quarter and half year ended September 30, 2026. 3. The Company operates in only one reportable segment viz., 'Pharmaceuticals ' in accordance with Ind AS 108, Operating Segment. 4. The Board of Directors of the Company at its meeting held on April 06, 2026 approved the transfer of domestic branded generic pharmaceutical formulations products business on a going concern basis through a Business Transfer Agreement (“BTA”) to Auropharm Limited (previously known as Auro Pharma Limited), a wholly owned subsidiary of the Company on a going concern basis w.e.f April 01, 2026. Accordingly, disclosure as required under Indian Accounting Standard (Ind AS) 105 Non-Current Assets Held for Sale and Discontinued Operations, in the standalone financial results for all the periods have been suitably presented. Particulars Quarter ended Half year ended Year ended 30.09.2026 30.06.2026 30.09.2025 30.09.2026 30.09.2025 31.03.2026 Total income - - 597.9 - 1,111.3 2,016.8 Total expenses - - 609.2 - 1,145.8 2,203.2 Loss before tax - - (11.3) - (34.5) (186.4) Tax expenses - - (2.6) - (8.4) (44.1) Loss for the period - - (8.7) - (26.1) (142.3) Cash flow from discontinued operations For the half year ended 30.09.2026 For the half year ended 30.09.2025 Cash flow generated from operating activities - (35.00) Cash flow used in investing activities - - Cash flow used in financing activities - (0.10) - (35.10) 5.During the year ended March 31, 2026, the Government of India consolidated 29 existing labour legislations into a unified framework comprising four labour codes as follows: Code on Wages, 2019, Code on Social Security, 2020, Industrial Relations Code, 2020 and Occupational Safety, Health and Working Conditions Code, 2020 (collectively referred to as the New Labour Codes). The New Labour Codes are effective from November 21, 2025 and introduce changes that include, among other things, setting a uniform definition of wages. The Government is in the process of issuing related rules. The New Labour Codes have implications on employee benefits including gratuity, leave encashment, and other related obligations. The Company assessed the implications of the New Labour Codes and recognized an incremental cost of Rs. 173.8 million during the year ended March 31, 2026. 6.The Board of Directors of Company at their meeting held on April 06, 2026, approved buyback of 5,423,728 fully paid-up equity shares of face value of Rs. 1 each (representing 0.93% of the total number of equity shares of the Company) for an aggregate value not exceeding Rs. 8,000.0 million (buyback size) (excluding transaction cost) at a maximum buyback price of Rs. 1,475 per equity share. Upon completion of the buyback, the Company extinguished the equity shares in compliance with applicable rules and regulations. Consequently, the paid-up equity share capital has been reduced by Rs. 5.4 million. The aggregate amount paid for buyback is Rs. 8,058 million including related expenses. 7.The Board of Directors at their meeting held on November 4, 2026 declared an interim dividend of Rs. 7 per equity share (Face value Rs. 1).



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2026
Date of end of reporting period 30-09-2026
Whether results are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 2,47,079.00
Capital work-in-progress 22,406.00
Investment property 0.00
Goodwill 0.00
Other intangible assets 944.00
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 17,58,107.00
Trade receivables, non-current
Loans, non-current 1,15,886.00
Other non-current financial assets
1 Other financial assets 5,032.00
Total of other non-current financial assets 5,032.00
Total non-current financial assets 18,79,025.00
Deferred tax assets (net)
Other non-current assets
1 Income tax assets (net) 3,949.00
2 Other non-current assets 11,101.00
Total of other non-current assets 15,050.00
Total non-current assets 21,64,504.00
2 Current assets
Inventories 2,44,441.00
Current financial asset
Current investments 3.00
Trade receivables, current 4,99,203.00
Cash and cash equivalents 9,739.00
Bank balance other than cash and cash equivalents 203.00
Loans, current 605.00
Other current financial assets
Total of other current financial assets 2,256.00
Total current financial assets 5,12,009.00
Current tax assets (net)
Other current assets
1 Other current assets 60,968.00
Total of other current assets 60,968.00
Total current assets 8,17,418.00
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 29,81,922.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 5,754.00
Other equity 23,31,673.00
Total equity attributable to owners of parent 23,37,427.00
Non controlling interest
Total equity 23,37,427.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1 Lease liabilities 7,610.00
Total of other non-current financial liabilities 7,610.00
Total non-current financial liabilities 7,610.00
Provisions, non-current 6,598.00
Deferred tax liabilities (net) 10,328.00
Deferred government grants, Non-current
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 24,536.00
Current liabilities
Current financial liabilities
Borrowings, current 3,88,939.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 5,218.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 1,78,366.00
Total Trade payable 1,83,584.00
Other current financial liabilities
1 Lease liabilities 1,991.00
2 Other financial liabilities 19,036.00
Total of other current financial liabilities 21,027.00
Total current financial liabilities 5,93,550.00
Other current liabilities 3,724.00
1 Other current liabilities 3,724.00
Total of other current liabilities 3,724.00
Provisions, current 2,952.00
Current tax liabilities (Net) 19,733.00
Deferred government grants, Current
Total current liabilities 6,19,959.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 6,44,495.00
Total equity and liabilites 29,81,922.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-07-2026 01-04-2026
Date of end of reporting period 30-09-2026 30-09-2026
Whether results are audited or unaudited Unaudited Unaudited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-07-2026 01-04-2026
B Date of end of reporting period 30-09-2026 30-09-2026
C Whether results are audited or unaudited Unaudited Unaudited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 (a) Re-measurement of defined benefit liability (604.00) (568.00)
Total Amount of items that will not be reclassified to profit and loss (604.00) (568.00)
2 Income tax relating to items that will not be reclassified to profit or loss (152.00) (143.00)
3 Amount of items that will be reclassified to profit and loss
1 a) Fair value change on derivatives designated as cash flow hedge (net) 780.00 780.00
Total Amount of items that will be reclassified to profit and loss 780.00 780.00
4 Income tax relating to items that will be reclassified to profit or loss 196.00 196.00
5 Total Other comprehensive income 132.00 159.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2026
B Date of end of reporting period 30-09-2026
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 1,97,903.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 9,436.00
Adjustments for decrease (increase) in inventories (11,965.00)
Adjustments for decrease (increase) in trade receivables, current (72,477.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (7,001.00)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current (206.00)
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 2,003.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (399.00)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 13,851.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 411.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 2,455.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (10,097.00)
Adjustments for dividend income 0.00
Adjustments for interest income 16,480.00
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow (2,752.00)
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 58.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (93,163.00)
Net cash flows from (used in) operations 1,04,740.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 12,491.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 92,249.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 14,321.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 83,716.00
Other cash payments to acquire equity or debt instruments of other entities 7,299.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 65.00
Purchase of property, plant and equipment 15,501.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 68,200.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 12,294.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 4.00
Net cash flows from (used in) investing activities 19,400.00
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 80,580.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 27,056.00
Repayments of borrowings 58,000.00
Payments of lease liabilities 1,203.00
Dividends paid 4.00
Interest paid 8,974.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (1,21,705.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (10,056.00)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 3,752.00
Net increase (decrease) in cash and cash equivalents (6,304.00)
Cash and cash equivalents cash flow statement at beginning of period 16,043.00
Cash and cash equivalents cash flow statement at end of period 9,739.00





Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Aurobindo Pharma Limited ALCEDO PHARMACHEM PRIVATE LIMITED Enterprises over which key management personnel or their relatives exercise significant influence Purchase of goods or services 8,600.00 Nil 4,062.50 1,364.70 1,115.80
2 Aurobindo Pharma Limited ALL PHARMA (SHANGHAI) TRADING CO.,LTD subsidiary Purchase of goods or services 193.00 Nil 59.80 268.40 177.10
3 Aurobindo Pharma Limited APL HEALTHCARE LIMITED subsidiary Purchase of goods or services 5,000.00 Nil 4,336.20 205.50 3,927.00
4 Aurobindo Pharma Limited ARROW GENERIQUES subsidiary Purchase of goods or services Nil 0.00 5.10 0.00
5 Aurobindo Pharma Limited AURO PEPTIDES LIMITED subsidiary Purchase of goods or services 2,183.00 Nil 916.80 0.00 6.40
6 Aurobindo Pharma Limited AURO PR INC subsidiary Purchase of goods or services Nil 0.00 5.00 0.00
7 Aurobindo Pharma Limited AUROBINDO PHARMA USA INC subsidiary Purchase of goods or services 528.00 Nil 0.60 3.30 0.00
8 Aurobindo Pharma Limited AUROLIFE PHARMA LLC subsidiary Purchase of goods or services 50.00 Nil 20.30 347.30 170.10
9 Aurobindo Pharma Limited AXIS CLINICALS LTD, India Enterprises over which key management personnel or their relatives exercise significant influence Purchase of goods or services 9,500.00 Nil 4,732.60 1,956.10 2,797.90
10 Aurobindo Pharma Limited East Pharma Techonologies, India Enterprises over which key management personnel or their relatives exercise significant influence Purchase of goods or services 5,000.00 Nil 363.20 164.00 81.30
11 Aurobindo Pharma Limited EUGIA PHARMA INDUSTRIA FARMACEUTICA LIMITADA subsidiary Purchase of goods or services Nil 0.00 13.40 13.60
12 Aurobindo Pharma Limited EUGIA PHARMA SPECIALITIES LIMITED subsidiary Purchase of goods or services 2,500.00 Nil 160.80 403.30 0.00
13 Aurobindo Pharma Limited Gelcaps Industries, India Enterprises over which key management personnel or their relatives exercise significant influence Purchase of goods or services 10,500.00 Nil 4,259.70 2,856.50 1,885.50
14 Aurobindo Pharma Limited GENERIS FARMACEUTICA SA subsidiary Purchase of goods or services 5.00 Nil 2.10 0.00 0.00
15 Aurobindo Pharma Limited NVNR (Ramannapet I) Power Plant Private Limited, India Associate Company Purchase of goods or services 1,400.00 Nil 518.80 201.60 139.60
16 Aurobindo Pharma Limited NVNR (Ramannapet II) Power Plant Private Limited, India Associate Company Purchase of goods or services 700.00 Nil 213.00 131.10 12.10
17 Aurobindo Pharma Limited Orem Access Bio INC Enterprises over which key management personnel or their relatives exercise significant influence Purchase of goods or services 3,215.00 Nil 1,957.60 500.20 434.10
18 Aurobindo Pharma Limited Pranit Packaging Private Limited, India Enterprises over which key management personnel or their relatives exercise significant influence Purchase of goods or services Nil 0.10 0.80 0.00
19 Aurobindo Pharma Limited Sri Sai Packaging, India Enterprises over which key management personnel or their relatives exercise significant influence Purchase of goods or services 2,700.00 Nil 1,372.50 279.90 333.20
20 Aurobindo Pharma Limited Transaction Square LLP, India Enterprises over which key management personnel or their relatives exercise significant influence Purchase of goods or services 100.00 Nil 27.60 16.30 25.00
21 Aurobindo Pharma Limited AUROBINDO PHARMA INDUSTRIA FARMACEUTICA LTDA subsidiary Purchase of goods or services 35.00 Nil 14.50 28.80 29.10
22 Aurobindo Pharma Limited APITORIA PHARMA PRIVATE LIMITED subsidiary Purchase of goods or services 2,60,694.00 Nil 1,06,485.10 56,524.90 63,271.60
23 Aurobindo Pharma Limited AURO ENTERPRISES (INDIA) PRIVATE LIMITED subsidiary Purchase of goods or services 2,500.00 Nil 990.50 (189.40) (177.60)
24 Aurobindo Pharma Limited AUROACTIVE PHARMA PRIVATE LIMITED subsidiary Purchase of goods or services 16.00 Nil 7.80 8.70 8.40
25 Aurobindo Pharma Limited VALUCOR PACKAGING PRIVATE LIMITED Enterprises over which key management personnel or their relatives exercise significant influence Purchase of goods or services 3,800.00 Nil 1,766.20 492.70 618.10
26 Aurobindo Pharma Limited ACROTECH BIOPHARMA LLC subsidiary Sale of goods or services 1.00 Nil 0.30 0.00 0.00
27 Aurobindo Pharma Limited APL HEALTH CARE LIMITED subsidiary Sale of goods or services 16,585.00 Nil 7,639.70 1,640.40 1,332.80
28 Aurobindo Pharma Limited APL PHARMA THAI LTD subsidiary Sale of goods or services 1,656.00 Nil 30.30 231.10 38.50
29 Aurobindo Pharma Limited APL Swift Services (Malta) Ltd. subsidiary Sale of goods or services 2,44,989.00 Nil 76,186.90 87,614.50 94,571.60
30 Aurobindo Pharma Limited ARROW GENERIQUES subsidiary Sale of goods or services 97,118.00 Nil 47,870.00 23,969.40 42,293.00
31 Aurobindo Pharma Limited AURO PEPTIDES LIMITED subsidiary Sale of goods or services 802.00 Nil 349.60 64.80 193.40
32 Aurobindo Pharma Limited AURO PHARMA INC subsidiary Sale of goods or services 50,338.00 Nil 24,845.20 35,882.60 26,704.40
33 Aurobindo Pharma Limited AURO PR INC subsidiary Sale of goods or services 15.00 Nil 5.90 0.00 0.50
34 Aurobindo Pharma Limited AUROACTIVE PHARMA PRIVATE LIMITED subsidiary Sale of goods or services 82.00 Nil 3.80 0.00 0.00
35 Aurobindo Pharma Limited AUROBINDO PHARMA (ITALIA) SRL subsidiary Sale of goods or services 8,329.00 Nil 22.10 2.90 22.10
36 Aurobindo Pharma Limited AUROBINDO PHARMA (PTY) LTD subsidiary Sale of goods or services 313.00 Nil 141.20 195.40 144.30
37 Aurobindo Pharma Limited Aurobindo Pharma B.V. subsidiary Sale of goods or services 18,348.00 Nil 8,584.40 3,501.10 6,819.40
38 Aurobindo Pharma Limited AUROBINDO PHARMA COLOMBIA SAS subsidiary Sale of goods or services 2,527.00 Nil 1,215.90 1,114.70 1,401.90
39 Aurobindo Pharma Limited AUROBINDO PHARMA FZ LLC subsidiary Sale of goods or services 328.00 Nil 46.20 389.70 130.10
40 Aurobindo Pharma Limited Aurobindo Pharma Industria Farmaceutica Ltda. subsidiary Sale of goods or services 1,717.00 Nil 672.50 285.50 484.80
41 Aurobindo Pharma Limited AUROBINDO PHARMA SAUDI ARABIA LIMITED subsidiary Sale of goods or services 300.00 Nil 140.70 0.00 143.80
42 Aurobindo Pharma Limited AUROBINDO PHARMA USA., INC subsidiary Sale of goods or services 4,31,903.00 Nil 2,04,995.70 1,31,603.10 1,68,332.90
43 Aurobindo Pharma Limited AUROGEN SOUTH AFRICA (PTY) LTD subsidiary Sale of goods or services 5,205.00 Nil 1,257.10 1,185.00 811.10
44 Aurobindo Pharma Limited AUROHEALTH LLC subsidiary Sale of goods or services 31,500.00 Nil 15,691.50 8,637.20 12,258.50
45 Aurobindo Pharma Limited AUROLIFE PHARMA LLC subsidiary Sale of goods or services 20.00 Nil 9.90 11.20 10.00
46 Aurobindo Pharma Limited AUROVIDA FARMACEUTICA, SA DE CV subsidiary Sale of goods or services 7,693.00 Nil 2,782.00 11,705.60 9,661.20
47 Aurobindo Pharma Limited AUROVITAS PHARMA TAIZHOU CO. , LTD subsidiary Sale of goods or services 5,010.00 Nil 79.20 554.70 616.30
48 Aurobindo Pharma Limited AUROVITAS SPAIN S.A.U. subsidiary Sale of goods or services 2,500.00 Nil 862.10 587.60 798.70
49 Aurobindo Pharma Limited CURATEQ BIOLOGICS PRIVATE LIMITED subsidiary Sale of goods or services 38.00 Nil 0.00 12.30 0.00
50 Aurobindo Pharma Limited EUGIA PHARMA (MALTA) LTD subsidiary Sale of goods or services 578.00 Nil 0.00 117.40 0.00
51 Aurobindo Pharma Limited EUGIA PHARMA INDUSTRIA FARMACEUTICA LIMITADA subsidiary Sale of goods or services 4,088.00 Nil (54.20) 108.90 39.70
52 Aurobindo Pharma Limited EUGIA PHARMA SPECIALITIES LIMITED subsidiary Sale of goods or services 15,432.00 Nil 7,181.20 14,942.00 10,838.30
53 Aurobindo Pharma Limited EUGIA SEZ PRIVATE LIMITED subsidiary Sale of goods or services 49.00 Nil 1.20 0.20 0.00
54 Aurobindo Pharma Limited EUGIA STERILES PRIVATE LIMITED subsidiary Sale of goods or services 9.00 Nil 3.80 1.50 0.70
55 Aurobindo Pharma Limited GENERIS FARMACEUTICA SA subsidiary Sale of goods or services 7,571.00 Nil 3,011.20 1,945.00 2,055.40
56 Aurobindo Pharma Limited LYFIUS PHARMA PRIVATE LIMITED subsidiary Sale of goods or services 329.00 Nil 7.50 0.00 3.20
57 Aurobindo Pharma Limited MILPHARM LIMITED subsidiary Sale of goods or services 43,025.00 Nil 21,367.30 11,338.30 19,761.30
58 Aurobindo Pharma Limited QULE PHARMA PRIVATE LIMITED subsidiary Sale of goods or services 781.00 Nil 4.80 0.00 0.00
59 Aurobindo Pharma Limited EUGIA PHARMA INC subsidiary Sale of goods or services 1,592.00 Nil 0.00 565.50 0.00
60 Aurobindo Pharma Limited APITORIA PHARMA PRIVATE LIMITED subsidiary Sale of goods or services 12,456.00 Nil 3,969.90 1,117.00 894.80
61 Aurobindo Pharma Limited EUGIA PHARMA COLOMBIA SAS subsidiary Sale of goods or services 1,365.00 Nil 0.00 157.60 0.00
62 Aurobindo Pharma Limited PT AUROGEN PHARMA INDONESIA subsidiary Sale of goods or services 500.00 Nil 130.10 25.90 0.00
63 Aurobindo Pharma Limited VESPYR BRANDS LLC subsidiary Sale of goods or services 500.00 Nil 14.00 124.60 9.50
64 Aurobindo Pharma Limited AUROPHARM LIMITED Subsidiary Sale of goods or services 1,500.00 Nil 411.50 0.00 360.40
65 Aurobindo Pharma Limited APITORIA PHARMA PRIVATE LIMITED subsidiary Any other transaction Sale of PPE 12,456.00 Nil 14.30 0.00 1.40
66 Aurobindo Pharma Limited QULE PHARMA PRIVATE LIMITED Subsidiary Any other transaction Sale of PPE 781.00 Nil 24.00 0.00 22.50
67 Aurobindo Pharma Limited APITORIA PHARMA PRIVATE LIMITED subsidiary Any other transaction Sale of Scrips 12,456.00 Nil 1,172.10 0.00 0.00
68 Aurobindo Pharma Limited LYFIUS PHARMA PRIVATE LIMITED Subsidiary Any other transaction Sale of Scrips 329.00 Nil 108.00 0.00 0.00
69 Aurobindo Pharma Limited QULE PHARMA PRIVATE LIMITED Subsidiary Any other transaction Sale of Scrips 781.00 Nil 45.70 0.00 0.00
70 Aurobindo Pharma Limited APL HEALTHCARE LIMITED subsidiary Any other transaction Rent received 16,585.00 Nil 37.20 0.00 0.00
71 Aurobindo Pharma Limited AURO PEPTIDES LIMITED subsidiary Any other transaction Rent received 802.00 Nil 79.10 0.00 0.00
72 Aurobindo Pharma Limited AUROACTIVE PHARMA PRIVATE LIMITED subsidiary Any other transaction Rent received 82.00 Nil 35.60 0.00 5.30
73 Aurobindo Pharma Limited THERANYM BIOLOGICS PRIVATE LIMITED Subsidiary Any other transaction Rent received 130.00 Nil 12.70 0.00 0.00
74 Aurobindo Pharma Limited APITORIA PHARMA PRIVATE LIMITED subsidiary Any other transaction Rent received 12,456.00 Nil 1,042.20 0.00 0.00
75 Aurobindo Pharma Limited AUROPHARM LIMITED Subsidiary Any other transaction Rent received 1,500.00 Nil 4.30 0.00 0.00
76 Aurobindo Pharma Limited QULE PHARMA PRIVATE LIMITED subsidiary Any other transaction collection of loan given including Interest Nil 65.30 0.00 0.00
77 Aurobindo Pharma Limited CURATEQ BIOLOGICS PRIVATE LIMITED Subsidiary Any other transaction collection of loan given including Interest Nil 97.10 0.00 0.00
78 Aurobindo Pharma Limited APITORIA PHARMA PRIVATE LIMITED subsidiary Any other transaction Conversion of Debentures CCD to OCD Nil 25,000.00 0.00 0.00
79 Aurobindo Pharma Limited AUROZEST PRIVATE LIMITED Subsidiary Any other transaction Conversion of Debentures CCD to OCD Nil 4,450.00 0.00 0.00
80 Aurobindo Pharma Limited APITORIA PHARMA PRIVATE LIMITED subsidiary Any other transaction Redemption of Debentures OCD Nil 10,000.00 0.00 0.00
81 Aurobindo Pharma Limited Aurobindo Pharma Foundation, India ( Sec.8 Company ) Enterprises over which key management personnel or their relatives exercise significant influence Any other transaction Contribution towards CSR activities Nil 2,700.00 0.00 0.00
82 Aurobindo Pharma Limited CURATEQ BIOLOGICS PRIVATE LIMITED subsidiary Any other transaction Commission on Corporate Guarantee received Nil 0.00 12.30 0.00
83 Aurobindo Pharma Limited Mr. K. Nityananda Reddy, Whole-time Director Key managerial personnel Any other transaction Rent expenses (Receiving of services) 50.00 Nil 19.00 2.80 0.00
84 Aurobindo Pharma Limited Raidurgam Developers Limited, India (JV) Joint ventures Any other transaction Rent expenses including maintainance. & Deposit 4,700.00 Nil 1,737.00 49.20 0.00
85 Aurobindo Pharma Limited CURATEQ BIOLOGICS PRIVATE LIMITED subsidiary Interest received Nil 239.00 0.00 0.00
86 Aurobindo Pharma Limited LYFIUS PHARMA PRIVATE LIMITED subsidiary Interest received Nil 174.90 0.00 0.00
87 Aurobindo Pharma Limited QULE PHARMA PRIVATE LIMITED subsidiary Interest received Nil 39.70 0.00 0.00
88 Aurobindo Pharma Limited Aurozest Private Limited subsidiary Interest received Nil 45.90 0.00 0.00
89 Aurobindo Pharma Limited GLS Pharma Limited Subsidiary Interest received Nil 95.80 0.00 0.00
90 Aurobindo Pharma Limited Apitoria Pharma Private Limited subsidiary Interest received Nil 268.20 0.00 0.00
91 Aurobindo Pharma Limited Auroactive Pharma Private Limited Subsidiary Interest received Nil 28.20 0.00 0.00
92 Aurobindo Pharma Limited Raidurgam Developers Limited subsidiary Interest received Nil 281.40 0.00 0.00
93 Aurobindo Pharma Limited THERANYM BIOLOGICS PRIVATE LIMITED Subsidiary Interest received Nil 16.90 0.00 0.00
94 Aurobindo Pharma Limited AURO VACCINES PRIVATE LIMITED subsidiary Interest received Nil 274.50 0.00 0.00
95 Aurobindo Pharma Limited CURATEQ BIOLOGICS PRIVATE LIMITED subsidiary Interest received Nil 1,507.70 0.00 0.00
96 Aurobindo Pharma Limited LYFIUS PHARMA PRIVATE LIMITED subsidiary Interest received Nil 222.70 0.00 0.00
97 Aurobindo Pharma Limited QULE PHARMA PRIVATE LIMITED subsidiary Interest received Nil 829.70 0.00 0.00
98 Aurobindo Pharma Limited Auroactive Pharma Private Limited Subsidiary Interest received Nil 276.00 0.00 0.00
99 Aurobindo Pharma Limited THERANYM BIOLOGICS PRIVATE LIMITED Subsidiary Interest received Nil 294.10 0.00 0.00
100 Aurobindo Pharma Limited GLS Pharma Limited Subsidiary Interest received Nil 56.40 0.00 0.00
101 Aurobindo Pharma Limited AUROPHARM LIMITED Subsidiary Interest received Nil 1,212.50 0.00 0.00
102 Aurobindo Pharma Limited LYFIUS PHARMA PRIVATE LIMITED subsidiary Loan Nil 200.40 6,096.20 6,296.60
103 Aurobindo Pharma Limited QULE PHARMA PRIVATE LIMITED Subsidiary Loan Nil 6,646.80 20,718.80 8,929.20
104 Aurobindo Pharma Limited AURO VACCINES PRIVATE LIMITED subsidiary Loan Nil 247.10 7,749.40 7,996.40
105 Aurobindo Pharma Limited CURATEQ BIOLOGICS PRIVATE LIMITED subsidiary Loan Nil 44,057.00 38,060.00 23,002.60
106 Aurobindo Pharma Limited AUROACTIVE PHARMA PRIVATE LIMITED Subsidiary Loan Nil 4,848.40 5,151.10 9,999.50
107 Aurobindo Pharma Limited THERANYM BIOLOGICS PRIVATE LIMITED Subsidiary Loan Nil 264.60 8,773.00 9,037.70
108 Aurobindo Pharma Limited GLS PHARMA LIMITED Subsidiary Loan Nil 50.80 1,572.90 1,623.70
109 Aurobindo Pharma Limited AUROPHARM LIMITED Subsidiary Loan Nil 16,091.30 32,532.60 48,623.90
110 Aurobindo Pharma Limited Engenra Biologics Private Limited Subsidiary Investment Nil 10.00 0.00 0.00
111 Aurobindo Pharma Limited Swarnaakshu Solar Power Private Limited Associate Company Investment Nil 117.00 0.00 0.00
112 Aurobindo Pharma Limited Garuda Renewables Private Limited Associate Company Investment 6,600.00 Nil 140.30 0.00 0.00
113 Aurobindo Pharma Limited AURO PEPTIDES LIMITED subsidiary Investment Nil 3,300.00 0.00 0.00
114 Aurobindo Pharma Limited CURATEQ BIOLOGICS PRIVATE LIMITED subsidiary Investment Nil 19.70 0.00 0.00
115 Aurobindo Pharma Limited THERANYM BIOLOGICS PRIVATE LIMITED Subsidiary Investment Nil 3,400.00 0.00 0.00
116 Aurobindo Pharma Limited SWARNAAKSHU SOLAR POWER PRIVATE LIMITED Associate Company Investment Nil 312.00 0.00 0.00
117 Aurobindo Pharma Limited SWARNAAKSHU SOLAR POWER PRIVATE LIMITED Associate Company Investment Nil 312.00 0.00 0.00
118 Aurobindo Pharma Limited QULE PHARMA PRIVATE LIMITED Subsidiary Any other transaction Loan to CCD Nil 18,371.00 0.00 0.00
119 Aurobindo Pharma Limited CURATEQ BIOLOGICS PRIVATE LIMITED Subsidiary Any other transaction Loan to CCD Nil 59,017.30 0.00 0.00
120 Aurobindo Pharma Limited Mr. K. Nithyananda Reddy, Whole-time Director Key managerial personnel Remuneration Nil 258.80 0.00 0.00
121 Aurobindo Pharma Limited P SARATH CHANDRA REDDY Key managerial personnel Any other transaction Director sitting fee paid Nil 3.00 0.00 0.00
122 Aurobindo Pharma Limited PENAKA VENKATA RAMA PRASAD REDDY Key managerial personnel Any other transaction Director sitting fee paid Nil 2.00 0.00 0.00
123 Aurobindo Pharma Limited M. Madan Mohan Reddy, Wholetime Director Key managerial personnel Remuneration Nil 330.20 0.00 0.00
124 Aurobindo Pharma Limited Santhanam Subramanian, Chief Financial Officer Key managerial personnel Remuneration Nil 375.40 0.00 0.00
125 Aurobindo Pharma Limited B. Adi Reddy, Company Secretary Key managerial personnel Remuneration Nil 47.00 0.00 0.00
126 Helix Healthcare B.V. Agile Pharma B.V. subsidiary Interest received Not Applicable 365.00 124.40 246.90
127 Helix Healthcare B.V. Agile Pharma B.V. subsidiary Loan Not Applicable 0.00 23,226.80 23,196.50
128 Helix Healthcare B.V. Milpharm Limited subsidiary Interest received Not Applicable 115.70 39.50 156.30
129 Helix Healthcare B.V. Milpharm Limited subsidiary Loan Not Applicable 0.00 5,518.60 5,568.20
130 Helix Healthcare B.V. Aurovitas Pharma (Taizhou) Ltd subsidiary Interest received Not Applicable 274.20 4,646.00 4,963.50
131 Helix Healthcare B.V. Aurovitas Pharma (Taizhou) Ltd subsidiary Loan Not Applicable 0.00 10,927.10 11,025.20
132 Helix Healthcare B.V. Aurosalud SA De CV subsidiary Loan Not Applicable 0.00 6,366.20 6,423.40
133 Helix Healthcare B.V. Aurosalud SA De CV subsidiary Interest received Not Applicable 167.00 1,136.90 1,315.10
134 Helix Healthcare B.V. PT Aurogen Pharma Indonesia subsidiary Loan Not Applicable 0.00 3,563.20 3,595.20
135 Helix Healthcare B.V. PT Aurogen Pharma Indonesia subsidiary Interest received Not Applicable 88.00 10.10 98.70
136 Helix Healthcare B.V. Auro PR Inc subsidiary Interest received Not Applicable 96.90 60.10 158.00
137 Helix Healthcare B.V. Auro PR Inc subsidiary Loan Not Applicable 0.00 3,325.60 4,314.20
138 Helix Healthcare B.V. Aurobindo Pharma B.V. subsidiary Interest received Not Applicable 7.30 0.00 0.00
139 Helix Healthcare B.V. Aurobindo Pharma B.V. subsidiary Advance Not Applicable 0.00 498.80 643.90
140 Helix Healthcare B.V. Aurobindo Pharma FZ-LLC subsidiary Any other transaction Other Receivable Not Applicable 0.00 0.00 979.70
141 Agile Pharma B.V. Puren Pharma GmbH & Co., KG subsidiary Dividend received Not Applicable 9,608.20 0.00 0.00
142 Agile Pharma B.V. Aurobindo Pharma B.V. subsidiary Interest received Not Applicable 2.00 0.10 0.00
143 Agile Pharma B.V. Aurobindo Pharma B.V. subsidiary Loan Not Applicable 0.00 327.00 0.00
144 Agile Pharma B.V. CuraTeQ Biologics s.r.o. subsidiary Loan Not Applicable 0.00 196.20 0.00
145 Agile Pharma B.V. CuraTeQ Biologics s.r.o. subsidiary Interest received Not Applicable 3.80 1.30 2.10
146 Agile Pharma B.V. Milpharm Limited subsidiary Sale of goods or services Not Applicable 109.40 0.00 108.40
147 Milpharm Limited Eugia Pharma (Malta) Limited subsidiary Sale of goods or services Not Applicable 338.60 46.70 49.90
148 Milpharm Limited CuraTeQ Biologics s.r.o. subsidiary Sale of goods or services Not Applicable 112.10 260.60 49.40
149 Milpharm Limited Eugia (UK) Limited subsidiary Advance Not Applicable 0.00 0.00 165.40
150 Milpharm Limited Ace Laboratories Limited subsidiary Any other transaction Other Receivable Not Applicable 0.00 0.00 0.60
151 Milpharm Limited Aurovitas Spain SA subsidiary Sale of goods or services Not Applicable 296.00 111.90 99.20
152 Milpharm Limited Aurobindo Pharma B.V. subsidiary Sale of goods or services Not Applicable 437.70 146.70 55.10
153 Milpharm Limited Puren Pharma GmbH & Co., KG subsidiary Sale of goods or services Not Applicable 311.90 50.70 51.20
154 Milpharm Limited Arrow generiques SAS subsidiary Sale of goods or services Not Applicable 871.20 844.70 434.00
155 Milpharm Limited Generis Farmaceutica S.A. subsidiary Sale of goods or services Not Applicable 495.60 97.40 148.60
156 Milpharm Limited Aurobindo Pharma (Italia) S.r.l subsidiary Sale of goods or services Not Applicable 205.30 74.30 57.40
157 Milpharm Limited Aurovitas Pharma Polska subsidiary Sale of goods or services Not Applicable 214.70 35.90 90.70
158 Milpharm Limited Aurobindo NV/SA subsidiary Sale of goods or services Not Applicable 93.30 13.10 12.10
159 Milpharm Limited APL Swift Services (Malta) Ltd subsidiary Sale of goods or services Not Applicable 216.40 14.60 13.20
160 Milpharm Limited CuraTeQ Biologics Private Limited subsidiary Sale of goods or services Not Applicable 9.10 1.50 10.60
161 Milpharm Limited Agile Pharma B.V. subsidiary Loan Not Applicable 0.00 753.10 954.50
162 Milpharm Limited Agile Pharma B.V. subsidiary Interest received Not Applicable 21.80 17.10 39.10
163 APL Swift Services (Malta) Ltd Eugia Pharma (Malta) Limited subsidiary Sale of goods or services Not Applicable 1,832.90 233.30 295.00
164 APL Swift Services (Malta) Ltd Eugia Pharma (Malta) Limited subsidiary Any other transaction Other income Not Applicable 1.80 0.00 0.00
165 APL Swift Services (Malta) Ltd Eugia Pharma (Malta) Limited subsidiary Any other transaction Rent received Not Applicable 13.20 0.00 0.00
166 APL Swift Services (Malta) Ltd Eugia Pharma (Malta) Limited subsidiary Interest received Not Applicable 0.00 0.20 0.20
167 APL Swift Services (Malta) Ltd Aurobindo Pharma (Italia) S.r.l subsidiary Sale of goods or services Not Applicable 9,682.90 3,263.20 7,262.50
168 APL Swift Services (Malta) Ltd Aurovitas Pharma Polska subsidiary Sale of goods or services Not Applicable 11,552.50 3,539.50 4,844.00
169 APL Swift Services (Malta) Ltd Aurobindo NV/SA subsidiary Sale of goods or services Not Applicable 8,137.80 2,318.30 4,267.80
170 APL Swift Services (Malta) Ltd Arrow generiques SAS subsidiary Sale of goods or services Not Applicable 6,736.80 3,711.40 3,779.20
171 APL Swift Services (Malta) Ltd Puren Pharma GmbH & Co., KG subsidiary Sale of goods or services Not Applicable 21,997.90 0.00 2,687.90
172 APL Swift Services (Malta) Ltd Puren Pharma GmbH & Co., KG subsidiary Interest received Not Applicable 8.30 5.00 13.30
173 APL Swift Services (Malta) Ltd Puren Pharma GmbH & Co., KG subsidiary Loan Not Applicable 0.00 439.50 444.50
174 APL Swift Services (Malta) Ltd Aurovitas Spain SA subsidiary Sale of goods or services Not Applicable 12,419.60 3,257.00 4,260.60
175 APL Swift Services (Malta) Ltd Aurobindo Pharma B.V. subsidiary Sale of goods or services Not Applicable 24,480.50 5,450.60 6,368.00
176 APL Swift Services (Malta) Ltd Aurobindo Pharma B.V. subsidiary Interest received Not Applicable 133.80 13.00 145.50
177 APL Swift Services (Malta) Ltd Aurobindo Pharma B.V. subsidiary Loan Not Applicable 0.00 10,899.50 10,885.30
178 APL Swift Services (Malta) Ltd Generis Farmaceutica S.A. subsidiary Sale of goods or services Not Applicable 21,099.40 8,863.80 8,755.50
179 APL Swift Services (Malta) Ltd Auro Pharma Inc. subsidiary Sale of goods or services Not Applicable 135.00 58.40 127.30
180 APL Swift Services (Malta) Ltd Milpharm Limited subsidiary Sale of goods or services Not Applicable 1,279.10 761.40 651.50
181 APL Swift Services (Malta) Ltd Milpharm Limited subsidiary Interest received Not Applicable 76.80 38.90 116.60
182 APL Swift Services (Malta) Ltd Milpharm Limited subsidiary Loan Not Applicable 0.00 4,001.70 4,041.90
183 APL Swift Services (Malta) Ltd Agile Pharma B.V. subsidiary Interest received Not Applicable 9.70 10.80 2.00
184 APL Swift Services (Malta) Ltd Agile Pharma B.V. subsidiary Loan Not Applicable 0.00 1,307.90 1,088.50
185 APL Swift Services (Malta) Ltd Aurobindo Pharma (Malta) Ltd subsidiary Any other transaction Other income Not Applicable 0.30 0.00 0.00
186 APL Swift Services (Malta) Ltd Aurobindo Pharma (Malta) Ltd subsidiary Sale of goods or services Not Applicable 0.00 21.70 3.70
187 APL Swift Services (Malta) Ltd CuraTeQ Biologics Private Limited subsidiary Sale of goods or services Not Applicable 0.00 26.40 26.40
188 APL Swift Services (Malta) Ltd CuraTeQ Biologics s.r.o. subsidiary Sale of goods or services Not Applicable 1,215.20 87.00 1,291.50
189 APL Swift Services (Malta) Ltd CuraTeQ Biologics B.V., Netherlands subsidiary Interest received Not Applicable 12.00 0.00 11.90
190 APL Swift Services (Malta) Ltd CuraTeQ Biologics B.V., Netherlands subsidiary Loan Not Applicable 0.00 0.00 2,340.30
191 APL Swift Services (Malta) Ltd CuraTeQ Biologics B.V., Netherlands subsidiary Any other transaction Other income Not Applicable 1.30 0.20 1.50
192 APL Swift Services (Malta) Ltd CuraTeQ Biologics (Malta) Limited subsidiary Interest received Not Applicable 6.70 0.00 6.60
193 APL Swift Services (Malta) Ltd CuraTeQ Biologics (Malta) Limited subsidiary Loan Not Applicable 0.00 0.00 1,632.80
194 APL Swift Services (Malta) Ltd CuraTeQ Biologics (Malta) Limited subsidiary Any other transaction Other income Not Applicable 0.80 340.80 494.70
195 APL Swift Services (Malta) Ltd Eugia Pharma B.V. subsidiary Any other transaction Other income Not Applicable 1.00 0.60 0.70
196 APL Swift Services (Malta) Ltd Eugia Pharma INC, Canada subsidiary Sale of goods or services Not Applicable 29.00 0.00 28.70
197 APL Swift Services (Malta) Ltd Aurovitas Pharma (Taizhou) Ltd subsidiary Any other transaction Other Receivable Not Applicable 0.00 508.50 71.00
198 Aurobindo Pharma (Malta) Ltd Aurovitas Pharma Polska subsidiary Sale of goods or services Not Applicable 20.60 0.00 0.00
199 Aurobindo Pharma (Malta) Ltd Aurovitas Spain SA subsidiary Sale of goods or services Not Applicable 30.30 0.00 0.00
200 Aurobindo Pharma (Malta) Ltd Arrow generiques SAS subsidiary Sale of goods or services Not Applicable 6.90 25.60 16.90
201 Aurobindo Pharma (Malta) Ltd APL Swift Services (Malta) Ltd subsidiary Interest received Not Applicable 5.40 138.90 5.30
202 Aurobindo Pharma (Malta) Ltd APL Swift Services (Malta) Ltd subsidiary Dividend received Not Applicable 0.00 1,987.40 1,984.80
203 Aurobindo Pharma (Malta) Ltd APL Swift Services (Malta) Ltd subsidiary Sale of goods or services Not Applicable 124.40 43.30 62.40
204 Aurobindo Pharma (Malta) Ltd APL Swift Services (Malta) Ltd subsidiary Loan Not Applicable 0.00 337.90 500.70
205 Aurobindo Pharma (Malta) Ltd Aurobindo Pharma B.V. subsidiary Sale of goods or services Not Applicable 40.40 0.00 0.30
206 Aurobindo Pharma (Malta) Ltd Aurobindo NV/SA subsidiary Sale of goods or services Not Applicable 1.20 0.00 0.00
207 Aurobindo Pharma (Malta) Ltd Generis Farmaceutica S.A. subsidiary Sale of goods or services Not Applicable 5.10 0.00 5.10
208 Aurobindo Pharma (Malta) Ltd Eugia Pharma (Malta) Limited subsidiary Sale of goods or services Not Applicable 0.00 1.80 0.00
209 Aurobindo Pharma (Malta) Ltd Puren Pharma GmbH & Co., KG subsidiary Sale of goods or services Not Applicable 48.60 2.60 0.80
210 Aurobindo Pharma (Malta) Ltd Puren Pharma GmbH & Co., KG subsidiary Interest received Not Applicable 1.30 0.80 2.10
211 Aurobindo Pharma (Malta) Ltd Puren Pharma GmbH & Co., KG subsidiary Loan Not Applicable 0.00 69.10 69.80
212 Aurobindo Pharma (Malta) Ltd Aurobindo Pharma (Italia) S.r.l subsidiary Sale of goods or services Not Applicable 6.60 0.00 6.10
213 Aurovitas Pharma Polska Arrow generiques SAS subsidiary Sale of goods or services Not Applicable 0.00 5.30 1.90
214 Aurovitas Pharma Polska Eugia Pharma (Malta) Limited subsidiary Any other transaction Reimbursement of expenses received Not Applicable 112.30 11.40 4.60
215 Aurovitas Pharma Polska Aurobindo NV/SA subsidiary Any other transaction Reimbursement of expenses received Not Applicable 20.50 6.30 8.10
216 Aurovitas Pharma Polska Puren Pharma GmbH & Co., KG subsidiary Any other transaction Reimbursement of expenses received Not Applicable 10.40 0.00 0.00
217 Aurovitas Pharma Polska Aurovitas Spain SA subsidiary Sale of goods or services Not Applicable 0.00 5.10 0.00
218 Aurovitas Pharma Polska Aurovitas Spain SA subsidiary Any other transaction Reimbursement of expenses received Not Applicable 0.40 0.00 0.00
219 Aurovitas Pharma Polska Aurobindo Pharma B.V. subsidiary Any other transaction Reimbursement of expenses received Not Applicable 2.00 0.00 0.00
220 Aurovitas Pharma Polska Aurobindo Pharma (Italia) S.r.l subsidiary Any other transaction Trade Receivable Not Applicable 0.00 0.00 0.10
221 Aurovitas Pharma Polska Aurobindo Pharma (Malta) Ltd subsidiary Any other transaction Trade Receivable Not Applicable 0.00 0.00 2.00
222 Generis Farmaceutica S.A. Milpharm Limited subsidiary Sale of goods or services Not Applicable 911.20 290.90 743.70
223 Generis Farmaceutica S.A. Milpharm Limited subsidiary Interest received Not Applicable 228.40 145.60 376.80
224 Generis Farmaceutica S.A. Milpharm Limited subsidiary Any other transaction Other income Not Applicable 46.00 0.00 0.00
225 Generis Farmaceutica S.A. Milpharm Limited subsidiary Loan Not Applicable 0.00 11,807.40 11,940.50
226 Generis Farmaceutica S.A. APL Swift Services (Malta) Ltd subsidiary Sale of goods or services Not Applicable 31.60 0.30 0.80
227 Generis Farmaceutica S.A. Aurobindo Pharma B.V. subsidiary Sale of goods or services Not Applicable 1,515.00 593.70 332.80
228 Generis Farmaceutica S.A. Aurobindo Pharma B.V. subsidiary Any other transaction Reimbursement of expenses received Not Applicable 115.20 0.00 0.00
229 Generis Farmaceutica S.A. Arrow generiques SAS subsidiary Sale of goods or services Not Applicable 3,134.00 1,236.50 738.80
230 Generis Farmaceutica S.A. Arrow generiques SAS subsidiary Any other transaction Reimbursement of expenses received Not Applicable 10.80 0.10 0.00
231 Generis Farmaceutica S.A. Puren Pharma GmbH & Co., KG subsidiary Sale of goods or services Not Applicable 1,471.00 318.00 75.70
232 Generis Farmaceutica S.A. Puren Pharma GmbH & Co., KG subsidiary Any other transaction Reimbursement of expenses received Not Applicable 34.80 0.00 0.00
233 Generis Farmaceutica S.A. Aurovitas Spain SA subsidiary Any other transaction Reimbursement of expenses received Not Applicable 12.20 0.00 0.00
234 Generis Farmaceutica S.A. Aurovitas Spain SA subsidiary Sale of goods or services Not Applicable 938.90 44.00 266.60
235 Generis Farmaceutica S.A. Aurovitas Pharma Polska subsidiary Sale of goods or services Not Applicable 197.30 6.00 23.50
236 Generis Farmaceutica S.A. Aurovitas Pharma Polska subsidiary Any other transaction Reimbursement of expenses received Not Applicable 12.30 0.00 0.00
237 Generis Farmaceutica S.A. Aurobindo Pharma (Italia) S.r.l subsidiary Sale of goods or services Not Applicable 470.00 48.70 143.50
238 Generis Farmaceutica S.A. Aurobindo Pharma (Italia) S.r.l subsidiary Any other transaction Reimbursement of expenses received Not Applicable 65.10 0.00 0.00
239 Generis Farmaceutica S.A. Aurobindo NV/SA subsidiary Sale of goods or services Not Applicable 117.40 171.00 64.00
240 Generis Farmaceutica S.A. Aurobindo NV/SA subsidiary Any other transaction Reimbursement of expenses received Not Applicable 19.40 0.00 0.00
241 Generis Farmaceutica S.A. Aurobindo Pharma (Malta) Ltd subsidiary Any other transaction Reimbursement of expenses received Not Applicable 18.10 0.00 13.60
242 Generis Farmaceutica S.A. APL Healthcare Limited subsidiary Any other transaction Reimbursement of expenses received Not Applicable 0.00 22.90 0.00
243 Aurobindo Pharma (Italia) S.r.l Eugia SEZ Private Limited subsidiary Sale of goods or services Not Applicable 0.00 1.40 1.40
244 Aurobindo Pharma (Italia) S.r.l Eugia Pharma (Malta) Limited subsidiary Sale of goods or services Not Applicable 341.40 179.50 95.30
245 Aurobindo Pharma (Italia) S.r.l Eugia Pharma (Malta) Limited subsidiary Any other transaction Miscellaneous Income Not Applicable 6.70 0.00 0.00
246 Aurobindo Pharma (Italia) S.r.l Aurovitas Spain SA subsidiary Sale of goods or services Not Applicable 0.00 4.00 0.00
247 Aurobindo Pharma (Italia) S.r.l Generis Farmaceutica S.A. subsidiary Sale of goods or services Not Applicable 4.80 0.50 2.10
248 Aurobindo Pharma (Italia) S.r.l Eugia Pharma Specialities Ltd subsidiary Sale of goods or services Not Applicable 0.00 34.50 34.50
249 Aurobindo Pharma (Italia) S.r.l Aurobindo Pharma B.V. subsidiary Sale of goods or services Not Applicable 12.80 0.00 0.00
250 Aurobindo Pharma (Italia) S.r.l Arrow generiques SAS subsidiary Sale of goods or services Not Applicable 21.30 1.90 1.90
251 Aurobindo Pharma (Italia) S.r.l Puren Pharma GmbH & Co., KG subsidiary Sale of goods or services Not Applicable 10.00 0.00 5.10
252 Aurobindo Pharma (Italia) S.r.l APL Swift Services (Malta) Ltd subsidiary Sale of goods or services Not Applicable 2.70 0.20 0.80
253 Aurobindo Pharma (Italia) S.r.l Aurobindo Pharma (Malta) Ltd subsidiary Sale of goods or services Not Applicable 1.00 0.00 0.00
254 Aurobindo Pharma (Italia) S.r.l Aurovitas Pharma Polska subsidiary Sale of goods or services Not Applicable 5.00 0.00 0.50
255 Aurobindo Pharma (Italia) S.r.l Aurobindo NV/SA subsidiary Sale of goods or services Not Applicable 1.00 0.00 1.00
256 Arrow generiques SAS Aurovitas Pharma Polska subsidiary Sale of goods or services Not Applicable 23.50 132.20 0.00
257 Arrow generiques SAS Agile Pharma B.V. subsidiary Interest received Not Applicable 238.30 15.80 251.90
258 Arrow generiques SAS Agile Pharma B.V. subsidiary Loan Not Applicable 0.00 6,539.70 0.00
259 Arrow generiques SAS Eugia Pharma (Malta) Limited subsidiary Sale of goods or services Not Applicable 0.00 639.10 0.00
260 Arrow generiques SAS Eugia Pharma (Malta) Limited subsidiary Any other transaction Reimbursement of expenses received Not Applicable 367.30 0.00 248.80
261 Arrow generiques SAS Generis Farmaceutica S.A. subsidiary Sale of goods or services Not Applicable 103.20 0.00 0.00
262 Arrow generiques SAS Generis Farmaceutica S.A. subsidiary Any other transaction Reimbursement of expenses received Not Applicable 9.50 0.00 0.00
263 Arrow generiques SAS Aurobindo Pharma (Italia) S.r.l subsidiary Sale of goods or services Not Applicable 430.60 10.50 0.00
264 Arrow generiques SAS Aurobindo NV/SA subsidiary Sale of goods or services Not Applicable 346.10 5.50 0.00
265 Arrow generiques SAS Aurobindo NV/SA subsidiary Any other transaction Reimbursement of expenses received Not Applicable 0.80 0.00 0.00
266 Arrow generiques SAS Puren Pharma GmbH & Co., KG subsidiary Sale of goods or services Not Applicable 5,610.40 26.20 1,311.90
267 Arrow generiques SAS Puren Pharma GmbH & Co., KG subsidiary Any other transaction Reimbursement of expenses received Not Applicable 10.30 0.00 0.00
268 Arrow generiques SAS Puren Pharma GmbH & Co., KG subsidiary Loan Not Applicable 0.00 0.00 17,416.40
269 Arrow generiques SAS Aurovitas Spain SA subsidiary Sale of goods or services Not Applicable 354.20 0.00 0.00
270 Arrow generiques SAS Aurovitas Spain SA subsidiary Any other transaction Reimbursement of expenses received Not Applicable 6.30 0.00 0.00
271 Arrow generiques SAS Aurobindo Pharma B.V. subsidiary Sale of goods or services Not Applicable 84.90 6.40 0.00
272 Arrow generiques SAS Aurobindo Pharma B.V. subsidiary Any other transaction Reimbursement of expenses received Not Applicable 16.30 0.00 0.00
273 Arrow generiques SAS Arrow Pharma Production SAS subsidiary Interest received Not Applicable 2.10 0.00 0.00
274 Arrow Pharma Production SAS Arrow generiques SAS subsidiary Sale of goods or services Not Applicable 77.80 0.00 30.00
275 Diadame Pharma Arrow generiques SAS subsidiary Sale of goods or services Not Applicable 192.30 175.20 49.20
276 Puren Pharma GmbH & Co., KG Agile Pharma B.V. subsidiary Interest received Not Applicable 486.50 75.60 264.50
277 Puren Pharma GmbH & Co., KG Agile Pharma B.V. subsidiary Loan Not Applicable 0.00 31,063.60 31,023.00
278 Puren Pharma GmbH & Co., KG Milpharm Limited subsidiary Sale of goods or services Not Applicable 155.10 37.40 52.40
279 Puren Pharma GmbH & Co., KG Milpharm Limited subsidiary Interest received Not Applicable 184.20 44.40 126.70
280 Puren Pharma GmbH & Co., KG Milpharm Limited subsidiary Loan Not Applicable 0.00 8,866.30 8,961.40
281 Puren Pharma GmbH & Co., KG APL Swift Services (Malta) Ltd subsidiary Any other transaction Other Receivable Not Applicable 0.00 11,772.40 0.00
282 Puren Pharma GmbH & Co., KG APL Swift Services (Malta) Ltd subsidiary Sale of goods or services Not Applicable 67.60 11.60 33.60
283 Puren Pharma GmbH & Co., KG Aurovitas Spain SA subsidiary Sale of goods or services Not Applicable 1.60 0.00 0.00
284 Puren Pharma GmbH & Co., KG Arrow generiques SAS subsidiary Sale of goods or services Not Applicable 0.00 3.50 0.00
285 1980 Puren Pharma GmbH Puren Pharma GmbH & Co., KG subsidiary Any other transaction Miscellaneous Income Not Applicable 0.00 12.90 0.00
286 Aurovitas Spain SA Eugia Pharma (Malta) Limited subsidiary Sale of goods or services Not Applicable 84.20 3.80 0.00
287 Aurovitas Spain SA Agile Pharma B.V. subsidiary Interest received Not Applicable 40.90 17.20 0.00
288 Aurovitas Spain SA Agile Pharma B.V. subsidiary Loan Not Applicable 0.00 7,084.70 0.00
289 Aurovitas Spain SA Aurovitas Pharma Polska subsidiary Any other transaction Other Receivable Not Applicable 0.00 0.00 0.20
290 Aurovitas Spain SA Arrow generiques SAS subsidiary Sale of goods or services Not Applicable 11.40 58.40 0.00
291 Aurobindo Pharma B.V. Aurovitas Spain SA subsidiary Any other transaction Reimbursement of expenses received Not Applicable 3.00 0.00 0.00
292 Aurobindo Pharma B.V. APL Swift Services (Malta) Ltd subsidiary Sale of goods or services Not Applicable 93.60 10.40 35.40
293 Aurobindo Pharma B.V. Generis Farmaceutica S.A. subsidiary Sale of goods or services Not Applicable 183.50 65.00 115.10
294 Aurobindo Pharma B.V. Helix Healthcare B.V. subsidiary Loan Not Applicable 0.00 1,984.40 0.00
295 Aurobindo Pharma B.V. Helix Healthcare B.V. subsidiary Interest received Not Applicable 8.20 16.80 0.00
296 Aurobindo Pharma B.V. Aurobindo NV/SA subsidiary Any other transaction Reimbursement of expenses received Not Applicable 0.90 0.00 0.80
297 Aurobindo Pharma B.V. Milpharm Limited subsidiary Loan Not Applicable 0.00 6,927.40 0.00
298 Aurobindo Pharma B.V. Milpharm Limited subsidiary Interest received Not Applicable 19.70 36.20 0.00
299 Aurobindo Pharma B.V. Aurovitas Nederland B.V subsidiary Interest received Not Applicable 267.50 0.00 221.30
300 Aurobindo Pharma B.V. Aurovitas Nederland B.V subsidiary Loan Not Applicable 0.00 14,831.20 14,811.80
301 Aurobindo Pharma B.V. Aurobindo Pharma (Italia) S.r.l subsidiary Any other transaction Reimbursement of expenses received Not Applicable 0.80 0.00 0.00
302 Aurobindo Pharma B.V. Agile Pharma B.V. subsidiary Interest received Not Applicable 522.60 59.30 271.10
303 Aurobindo Pharma B.V. Agile Pharma B.V. subsidiary Any other transaction Reimbursement of expenses received Not Applicable 0.90 0.00 0.00
304 Aurobindo Pharma B.V. Agile Pharma B.V. subsidiary Loan Not Applicable 0.00 33,180.00 33,680.80
305 Aurobindo Pharma B.V. Agile Pharma B.V. subsidiary Sale of goods or services Not Applicable 12.60 0.00 15.30
306 Aurobindo Pharma B.V. Puren Pharma GmbH & Co., KG subsidiary Any other transaction Reimbursement of expenses received Not Applicable 4.40 0.00 0.00
307 Aurobindo Pharma B.V. Aurovitas Pharma Polska subsidiary Any other transaction Reimbursement of expenses received Not Applicable 0.90 0.00 0.80
308 Aurovitas Nederland B.V Aurobindo Pharma B.V. subsidiary Interest received Not Applicable 0.20 0.00 0.00
309 Aurovitas Nederland B.V Aurobindo Pharma B.V. subsidiary Loan Not Applicable 0.00 59.90 0.00
310 Aurovitas Spol s.r.o Aurobindo Pharma (Italia) S.r.l subsidiary Interest received Not Applicable 40.80 24.50 65.10
311 Aurovitas Spol s.r.o Aurobindo Pharma (Italia) S.r.l subsidiary Loan Not Applicable 0.00 2,787.70 2,813.00
312 Aurovitas Spol s.r.o Agile Pharma B.V. subsidiary Interest received Not Applicable 47.70 7.40 54.60
313 Aurovitas Spol s.r.o Agile Pharma B.V. subsidiary Loan Not Applicable 0.00 3,041.10 3,068.70
314 CuraTeQ Biologics s.r.o. CuraTeQ Biologics Private Limited subsidiary Any other transaction Other Receivable Not Applicable 0.00 280.30 282.40
315 CuraTeQ Biologics s.r.o. Milpharm Limited subsidiary Sale of goods or services Not Applicable 570.90 0.00 567.60
316 CuraTeQ Biologics s.r.o. Arrow generiques SAS subsidiary Sale of goods or services Not Applicable 253.90 0.00 252.50
317 CuraTeQ Biologics s.r.o. Puren Pharma GmbH & Co., KG subsidiary Sale of goods or services Not Applicable 50.40 0.00 49.60
318 CuraTeQ Biologics s.r.o. Generis Farmaceutica S.A. subsidiary Sale of goods or services Not Applicable 151.40 0.00 150.50
319 CuraTeQ Biologics s.r.o. CuraTeQ Biologics (Malta) Limited subsidiary Sale of goods or services Not Applicable 385.80 0.00 128.50
320 CuraTeQ Biologics s.r.o. CuraTeQ Biologics (Malta) Limited subsidiary Sale of fixed assets Not Applicable 4,974.80 0.00 3,481.40
321 Apotex Europe B.V. Aurobindo NV/SA subsidiary Any other transaction Reimbursement of expenses received Not Applicable 17.30 0.00 0.00
322 Apotex Europe B.V. Aurobindo Pharma B.V. subsidiary Interest received Not Applicable 69.20 0.30 58.40
323 Apotex Europe B.V. Aurobindo Pharma B.V. subsidiary Loan Not Applicable 0.00 4,130.90 4,125.50
324 Apotex Europe B.V. APL Swift Services (Malta) Ltd subsidiary Any other transaction Reimbursement of expenses received Not Applicable 0.00 11.80 0.00
325 TheraNyM Biologics Private Limited CuraTeQ Biologics Private Limited subsidiary Any other transaction Other Receivable Not Applicable 0.00 7.90 6.00
326 CuraTeQ Biologics Private Limited TheraNyM Biologics Private Limited subsidiary Sale of goods or services Not Applicable 191.50 262.20 453.70
327 CuraTeQ Biologics Private Limited Auro Vaccines Private Limited subsidiary Interest received Not Applicable 141.40 0.00 0.00
328 CuraTeQ Biologics Private Limited Auro Vaccines Private Limited subsidiary Loan Not Applicable 0.00 1,924.20 3,827.60
329 CuraTeQ Biologics Private Limited Acrotech Biopharma Inc. subsidiary Any other transaction Trade Receivable Not Applicable 0.00 939.40 470.10
330 CuraTeQ Biologics Private Limited APL Swift Services (Malta) Ltd subsidiary Sale of goods or services Not Applicable 1,466.30 55.90 998.50
331 CuraTeQ Biologics Private Limited Aurovida Farmaceutica SA DE CV subsidiary Sale of goods or services Not Applicable 1,335.60 0.00 1,359.60
332 CuraTeQ Biologics Private Limited Auro Peptides Ltd subsidiary Any other transaction Other Receivable Not Applicable 0.00 0.00 4.90
333 Aurobindo NV/SA Milpharm Limited subsidiary Sale of goods or services Not Applicable 184.00 34.20 28.90
334 Aurobindo NV/SA Eugia Pharma (Malta) Limited subsidiary Sale of goods or services Not Applicable 36.10 7.70 0.00
335 Aurobindo NV/SA Aurobindo Pharma B.V. subsidiary Sale of goods or services Not Applicable 0.60 0.00 0.60
336 Aurobindo NV/SA Aurovitas Spain SA subsidiary Sale of goods or services Not Applicable 0.00 8.60 0.00
337 Aurobindo NV/SA Aurobindo Pharma (Italia) S.r.l subsidiary Sale of goods or services Not Applicable 0.60 0.00 0.60
338 Aurobindo NV/SA Generis Farmaceutica S.A. subsidiary Any other transaction Trade Receivable Not Applicable 0.00 0.90 0.00
339 Eugia Pharma Industria Farmaceutica Limitada Eugia SEZ Private Limited subsidiary Sale of goods or services Not Applicable 0.00 12.40 0.00
340 Eugia Pharma Industria Farmaceutica Limitada Eugia Pharma Specialities Ltd subsidiary Sale of goods or services Not Applicable 56.10 13.60 0.00
341 Eugia Pharma (Malta) Limited Aurovitas Pharma Polska subsidiary Sale of goods or services Not Applicable 282.50 0.00 116.20
342 Eugia Pharma (Malta) Limited APL Swift Services (Malta) Ltd subsidiary Interest received Not Applicable 35.20 156.40 34.80
343 Eugia Pharma (Malta) Limited APL Swift Services (Malta) Ltd subsidiary Loan Not Applicable 0.00 2,648.60 1,904.90
344 Eugia Pharma (Malta) Limited Aurobindo Pharma (Italia) S.r.l subsidiary Sale of goods or services Not Applicable 4,414.20 1,460.10 1,955.10
345 Eugia Pharma (Malta) Limited Milpharm Limited subsidiary Sale of goods or services Not Applicable 223.10 0.00 136.30
346 Eugia Pharma (Malta) Limited Generis Farmaceutica S.A. subsidiary Sale of goods or services Not Applicable 7,084.70 3,673.90 4,164.70
347 Eugia Pharma (Malta) Limited Arrow generiques SAS subsidiary Sale of goods or services Not Applicable 13,515.60 5,964.10 7,853.90
348 Eugia Pharma (Malta) Limited Arrow generiques SAS subsidiary Any other transaction Other income Not Applicable 3.30 0.00 0.00
349 Eugia Pharma (Malta) Limited Puren Pharma GmbH & Co., KG subsidiary Sale of goods or services Not Applicable 7,721.60 1,226.60 1,564.40
350 Eugia Pharma (Malta) Limited Aurovitas Spain SA subsidiary Sale of goods or services Not Applicable 14,947.00 5,592.80 5,367.10
351 Eugia Pharma (Malta) Limited Aurovitas Spain SA subsidiary Any other transaction Other income Not Applicable 9.70 0.00 0.00
352 Eugia Pharma (Malta) Limited Aurobindo Pharma B.V. subsidiary Sale of goods or services Not Applicable 2,223.00 667.60 1,117.60
353 Eugia Pharma (Malta) Limited Aurobindo NV/SA subsidiary Sale of goods or services Not Applicable 434.20 79.20 18.00
354 Eugia Pharma (Malta) Limited Eugia Pharma Specialities Ltd subsidiary Any other transaction Reimbursement of expenses received Not Applicable 183.50 0.00 0.00
355 Eugia Pharma B.V. Eugia Pharma (Malta) Limited subsidiary Dividend received Not Applicable 0.00 7,392.20 7,382.60
356 Eugia Pharma B.V. APL Swift Services (Malta) Ltd subsidiary Loan Not Applicable 0.00 1,743.90 1,741.60
357 Eugia Pharma B.V. APL Swift Services (Malta) Ltd subsidiary Interest received Not Applicable 20.00 10.90 12.50
358 Eugia (UK) Limited Milpharm Limited subsidiary Sale of goods or services Not Applicable 0.00 44.70 0.00
359 CuraTeQ Biologics (Malta) Limited CuraTeQ Biologics B.V., Netherlands subsidiary Any other transaction Other Receivable Not Applicable 0.00 1.30 0.00
360 CuraTeQ Biologics (Malta) Limited APL Swift Services (Malta) Ltd subsidiary Loan Not Applicable 0.00 0.00 3,809.80
361 CuraTeQ Biologics (Malta) Limited APL Swift Services (Malta) Ltd subsidiary Interest received Not Applicable 16.20 0.00 16.10
362 Ace Laboratories Limited Milpharm Limited subsidiary Sale of goods or services Not Applicable 591.50 47.40 1.50
363 Aurobindo Pharma Industria Farmaceutica Ltd Eugia Pharma Industria Farmaceutica Limitada subsidiary Any other transaction Rent received Not Applicable 24.10 0.00 0.00
364 Aurobindo Pharma Industria Farmaceutica Ltd CuraTeQ Biologics Private Limited subsidiary Sale of goods or services Not Applicable 6.90 3.30 10.30
365 All Pharma (Shanghai) Trading Co Ltd APL Healthcare Limited subsidiary Sale of goods or services Not Applicable 31.30 8.70 25.70
366 All Pharma (Shanghai) Trading Co Ltd Auro Peptides Ltd subsidiary Any other transaction Other Receivable Not Applicable 0.00 8.10 8.20
367 All Pharma (Shanghai) Trading Co Ltd Lyfius Pharma Private Limited subsidiary Sale of goods or services Not Applicable 74.30 71.60 22.70
368 All Pharma (Shanghai) Trading Co Ltd Eugia Pharma Specialities Ltd subsidiary Sale of goods or services Not Applicable 0.20 40.50 41.70
369 All Pharma (Shanghai) Trading Co Ltd Aurovitas Pharma (Taizhou) Ltd subsidiary Any other transaction Other Receivable Not Applicable 0.00 1,882.50 1,920.70
370 All Pharma (Shanghai) Trading Co Ltd Aurovitas Pharma (Taizhou) Ltd subsidiary Any other transaction Trade Receivable Not Applicable 0.00 0.00 71.40
371 Aurovitas Pharma (Taizhou) Ltd Auro Peptides Ltd subsidiary Any other transaction Other Receivable Not Applicable 0.00 50.40 52.50
372 Aurovitas Pharma (Taizhou) Ltd APL Swift Services (Malta) Ltd subsidiary Sale of goods or services Not Applicable 5,350.30 3,401.40 4,002.60
373 Aurovitas Pharma (Taizhou) Ltd All Pharma (Shanghai) Trading Co Ltd subsidiary Sale of goods or services Not Applicable 71.60 300.70 395.60
374 Aurovitas Pharma (Taizhou) Ltd Milpharm Limited subsidiary Sale of goods or services Not Applicable 1,782.00 541.10 1,563.10
375 Aurovitas Pharma (Taizhou) Ltd Aurobindo Pharma B.V. subsidiary Sale of goods or services Not Applicable 24.00 0.00 24.00
376 Aurovitas Pharma (Taizhou) Ltd Aurobindo Pharma USA Inc. subsidiary Sale of goods or services Not Applicable 960.30 0.00 379.30
377 Auro Pharma Inc. Eugia Pharma INC, Canada subsidiary Sale of goods or services Not Applicable 486.00 351.00 242.00
378 Auro Pharma Inc. CuraTeQ Biologics Private Limited subsidiary Any other transaction Trade Receivable Not Applicable 0.00 15.10 15.00
379 Auro Pharma Inc. Aurobindo Pharma USA Inc. subsidiary Any other transaction Other income Not Applicable 0.00 1.10 0.00
380 Aurobindo Pharma Saudi Arabia Limited Company Aurobindo Pharma FZ-LLC subsidiary Interest received Not Applicable 59.80 78.80 50.80
381 Aurobindo Pharma Saudi Arabia Limited Company Aurobindo Pharma FZ-LLC subsidiary Loan Not Applicable 0.00 2,842.90 2,870.70
382 Aurobindo Pharma FZ-LLC Aurovitas Pharma (Taizhou) Ltd subsidiary Interest received Not Applicable 40.10 177.90 220.20
383 Aurobindo Pharma FZ-LLC PT Aurogen Pharma Indonesia subsidiary Sale of goods or services Not Applicable 5,141.30 3,645.20 6,002.00
384 Aurobindo Pharma FZ-LLC PT Aurogen Pharma Indonesia subsidiary Interest received Not Applicable 156.00 159.00 318.00
385 Aurobindo Pharma FZ-LLC PT Aurogen Pharma Indonesia subsidiary Loan Not Applicable 0.00 7,344.60 7,421.40
386 Aurobindo Pharma FZ-LLC Aurovitas Pharma (Taizhou) Ltd subsidiary Loan Not Applicable 0.00 1,895.40 1,915.20
387 Lyfius Pharma Private Limited Qule Pharma Private Limited subsidiary Any other transaction Reimbursement of expenses received Not Applicable 1,040.40 0.00 0.00
388 Lyfius Pharma Private Limited Qule Pharma Private Limited subsidiary Any other transaction Rent received Not Applicable 1.50 0.00 0.00
389 Lyfius Pharma Private Limited Qule Pharma Private Limited subsidiary Sale of goods or services Not Applicable 36,042.80 27,431.70 37,102.40
390 Lyfius Pharma Private Limited Qule Pharma Private Limited subsidiary Sale of fixed assets Not Applicable 7.40 0.00 7.40
391 Lyfius Pharma Private Limited Auro Peptides Ltd subsidiary Sale of fixed assets Not Applicable 68.80 0.00 0.00
392 Lyfius Pharma Private Limited TheraNyM Biologics Private Limited subsidiary Sale of fixed assets Not Applicable 1.60 0.00 1.60
393 Aurobindo Pharma (Pty) Ltd Aurogen South Africa (PTY) Ltd subsidiary Sale of goods or services Not Applicable 0.50 0.40 0.60
394 Aurogen South Africa (PTY) Ltd Aurobindo Pharma (Pty) Ltd subsidiary Any other transaction Other Receivable Not Applicable 0.00 0.90 2.30
395 Aurogen South Africa (PTY) Ltd Purple Bellflower, South Africa subsidiary Loan Not Applicable 0.00 5.60 8.30
396 Aurosalud SA De CV Aurovida Farmaceutica SA DE CV subsidiary Any other transaction Other Receivable Not Applicable 0.00 7,547.70 7,698.80
397 Aurobindo Pharma Colombia S A S Aurovida Farmaceutica SA DE CV subsidiary Sale of goods or services Not Applicable 0.00 106.50 109.50
398 Aurobindo Pharma Colombia S A S Eugia Pharma Colombia S.A.S. subsidiary Sale of goods or services Not Applicable 228.40 1,928.10 1,612.70
399 Eugia Pharma Colombia S.A.S. Aurobindo Pharma Colombia S A S subsidiary Sale of goods or services Not Applicable 0.20 0.00 0.00
400 Eugia Pharma (Australia) PTY Limited Eugia Pharma Specialities Ltd subsidiary Sale of goods or services Not Applicable 91.40 603.50 0.00
401 Eugia Pharma (Australia) PTY Limited Eugia SEZ Private Limited subsidiary Sale of goods or services Not Applicable 0.00 14.50 0.00
402 Auro PR Inc Acrotech Biopharma Inc. subsidiary Any other transaction Reimbursement of expenses received Not Applicable 17.70 0.00 0.00
403 Aurobindo Pharma USA Inc. Auro PR Inc subsidiary Sale of goods or services Not Applicable 0.20 15.80 16.20
404 Aurobindo Pharma USA Inc. Eugia US Manufacturing LLC subsidiary Any other transaction Reimbursement of expenses received Not Applicable 0.00 0.40 0.00
405 Aurobindo Pharma USA Inc. Eugia US LLC subsidiary Sale of goods or services Not Applicable 102.20 64.70 63.30
406 Aurobindo Pharma USA Inc. Eugia US LLC subsidiary Any other transaction Other income Not Applicable 54.30 0.00 0.00
407 Aurobindo Pharma USA Inc. Eugia US LLC subsidiary Any other transaction Reimbursement of expenses received Not Applicable 63.30 0.00 0.00
408 Aurobindo Pharma USA Inc. Milpharm Limited subsidiary Sale of goods or services Not Applicable 271.10 84.40 169.60
409 Aurolife Pharma LLC APL Healthcare Limited subsidiary Sale of goods or services Not Applicable 0.00 268.50 0.00
410 Aurolife Pharma LLC APL Healthcare Limited subsidiary Any other transaction Reimbursement of expenses received Not Applicable 8.20 0.00 16.80
411 Aurolife Pharma LLC Aurovitas Pharma (Taizhou) Ltd subsidiary Any other transaction Trade Receivable Not Applicable 0.00 454.20 458.90
412 Auro Health LLC APL Healthcare Limited subsidiary Sale of goods or services Not Applicable 0.00 2.80 0.00
413 Acrotech Biopharma Inc. Auro PR Inc subsidiary Any other transaction Reimbursement of expenses received Not Applicable 0.20 17.50 0.00
414 AuroLogistics LLC Eugia US LLC subsidiary Sale of goods or services Not Applicable 2,118.80 557.20 1,814.20
415 Eugia US LLC Eugia Pharma Specialities Ltd subsidiary Any other transaction Other Receivable Not Applicable 0.00 145.10 14.60
416 Eugia US LLC Eugia Pharma INC, Canada subsidiary Sale of goods or services Not Applicable 0.00 35.80 0.00
417 Qule Pharma Private Limited Lyfius Pharma Private Limited subsidiary Any other transaction Rent received Not Applicable 0.40 0.00 0.00
418 Qule Pharma Private Limited Lyfius Pharma Private Limited subsidiary Sale of goods or services Not Applicable 2,453.60 122.60 3.60
419 Qule Pharma Private Limited Lyfius Pharma Private Limited subsidiary Sale of fixed assets Not Applicable 23.80 0.00 0.00
420 Qule Pharma Private Limited Auro Peptides Ltd subsidiary Sale of fixed assets Not Applicable 17.60 0.00 0.00
421 Qule Pharma Private Limited TheraNyM Biologics Private Limited subsidiary Sale of fixed assets Not Applicable 11.00 0.00 0.00
422 APL Healthcare Limited Milpharm Limited subsidiary Sale of goods or services Not Applicable 403.50 9.50 412.20
423 APL Healthcare Limited APL Swift Services (Malta) Ltd subsidiary Sale of goods or services Not Applicable 10,282.50 11,976.10 12,878.60
424 APL Healthcare Limited Generis Farmaceutica S.A. subsidiary Sale of goods or services Not Applicable 208.30 29.00 0.00
425 APL Healthcare Limited Arrow generiques SAS subsidiary Sale of goods or services Not Applicable 8.20 28.20 29.00
426 APL Healthcare Limited Aurovitas Spain SA subsidiary Sale of goods or services Not Applicable 297.80 23.70 68.50
427 APL Healthcare Limited Aurobindo Pharma B.V. subsidiary Sale of goods or services Not Applicable 3,492.10 2,041.90 3,523.80
428 APL Healthcare Limited Auro Pharma Inc. subsidiary Sale of goods or services Not Applicable 10,726.20 8,618.40 14,087.70
429 APL Healthcare Limited Aurobindo Pharma (Pty) Ltd subsidiary Sale of goods or services Not Applicable 10,950.80 22,909.30 18,556.40
430 APL Healthcare Limited Aurovida Farmaceutica SA DE CV subsidiary Sale of goods or services Not Applicable 329.20 4,848.60 5,240.20
431 APL Healthcare Limited Aurogen South Africa (PTY) Ltd subsidiary Sale of goods or services Not Applicable 3,092.70 9,587.70 12.20
432 APL Healthcare Limited Aurobindo Pharma FZ-LLC subsidiary Sale of goods or services Not Applicable 0.00 146.10 57.70
433 APL Healthcare Limited Aurobindo Pharma Colombia S A S subsidiary Sale of goods or services Not Applicable 371.50 0.00 375.50
434 APL Healthcare Limited Auropharm Limited subsidiary Sale of goods or services Not Applicable 129.50 0.00 0.00
435 APL Healthcare Limited Aurobindo Pharma USA Inc. subsidiary Sale of goods or services Not Applicable 1,38,589.90 70,803.00 1,29,348.20
436 APL Healthcare Limited Auro Health LLC subsidiary Sale of goods or services Not Applicable 14,401.90 7,926.00 13,833.30
437 APL Healthcare Limited Vespyr Brands LLC subsidiary Sale of goods or services Not Applicable 393.30 1,028.90 299.20
438 APL Healthcare Limited Aurolife Pharma LLC subsidiary Sale of goods or services Not Applicable 24.70 0.00 24.80
439 APL Healthcare Limited Eugia SEZ Private Limited subsidiary Any other transaction Reimbursement of expenses received Not Applicable 3.30 1.20 2.20
440 APL Healthcare Limited Qule Pharma Private Limited subsidiary Any other transaction Trade Receivable Not Applicable 0.00 0.00 5.60
441 AuroZest Private Limited TheraNyM Biologics Private Limited subsidiary Sale of fixed assets Not Applicable 4,450.10 0.00 4,405.60
442 Auro Peptides Ltd CuraTeQ Biologics Private Limited subsidiary Sale of goods or services Not Applicable 13.70 0.00 13.70
443 Auro Peptides Ltd Eugia Steriles Private Limited subsidiary Sale of goods or services Not Applicable 172.00 0.00 171.80
444 Auro Peptides Ltd Eugia Pharma Specialities Ltd subsidiary Sale of goods or services Not Applicable 368.10 99.90 186.40
445 Auro Peptides Ltd GLS Pharma Limited subsidiary Sale of goods or services Not Applicable 70.80 94.00 164.70
446 Auro Peptides Ltd Aurovitas Pharma (Taizhou) Ltd subsidiary Sale of goods or services Not Applicable 0.00 53.10 0.00
447 Auro Vaccines LLC Auro Vaccines Private Limited subsidiary Any other transaction Trade Receivable Not Applicable 0.00 36.70 37.10
448 Auro Vaccines Private Limited CuraTeQ Biologics Private Limited subsidiary Sale of fixed assets Not Applicable 274.10 0.00 274.10
449 Auro Vaccines Private Limited GLS Pharma Limited subsidiary Sale of fixed assets Not Applicable 34.80 0.00 34.80
450 Auro Vaccines Private Limited Eugia SEZ Private Limited subsidiary Sale of fixed assets Not Applicable 0.00 1,134.60 0.00
451 Eugia Steriles Private Limited Eugia Pharma Specialities Ltd subsidiary Sale of goods or services Not Applicable 203.40 147.60 0.00
452 Eugia Steriles Private Limited Eugia US LLC subsidiary Sale of goods or services Not Applicable 1,636.60 31.30 1,390.00
453 Eugia SEZ Private Limited Milpharm Limited subsidiary Sale of goods or services Not Applicable 0.00 484.00 0.00
454 Eugia SEZ Private Limited Aurogen South Africa (PTY) Ltd subsidiary Sale of goods or services Not Applicable 1,102.60 544.40 697.20
455 Eugia SEZ Private Limited Aurobindo Pharma FZ-LLC subsidiary Sale of goods or services Not Applicable 0.00 111.50 112.70
456 Eugia SEZ Private Limited Eugia Pharma (Australia) PTY Limited subsidiary Sale of goods or services Not Applicable 0.00 121.90 0.00
457 Eugia SEZ Private Limited Eugia Pharma (Malta) Limited subsidiary Sale of goods or services Not Applicable 3,557.80 2,290.80 1,200.70
458 Eugia SEZ Private Limited Eugia Pharma Industria Farmaceutica Limitada subsidiary Sale of goods or services Not Applicable 4,111.90 1,072.80 1,551.80
459 Eugia SEZ Private Limited Eugia Pharma Colombia S.A.S. subsidiary Sale of goods or services Not Applicable 0.00 546.50 0.00
460 Eugia SEZ Private Limited Eugia US LLC subsidiary Sale of goods or services Not Applicable 11,288.50 8,011.70 6,346.50
461 Eugia Pharma Specialities Ltd Eugia SEZ Private Limited subsidiary Any other transaction Trade Receivable Not Applicable 0.00 4.60 0.30
462 Eugia Pharma Specialities Ltd Auro vaccines Private Limited subsidiary Sale of fixed assets Not Applicable 153.40 0.00 153.30
463 Eugia Pharma Specialities Ltd Auro Pharma Inc. subsidiary Sale of goods or services Not Applicable 3,360.90 3,340.80 3,077.70
464 Eugia Pharma Specialities Ltd APL Pharma Thai Limited subsidiary Sale of goods or services Not Applicable 568.60 538.30 768.10
465 Eugia Pharma Specialities Ltd Eugia Pharma (Australia) PTY Limited subsidiary Sale of goods or services Not Applicable 320.90 371.50 343.30
466 Eugia Pharma Specialities Ltd Eugia Pharma INC, Canada subsidiary Sale of goods or services Not Applicable 5,945.50 4,619.10 4,826.50
467 Eugia Pharma Specialities Ltd Eugia Pharma (Malta) Limited subsidiary Sale of goods or services Not Applicable 19,846.20 9,518.40 8,895.30
468 Eugia Pharma Specialities Ltd Eugia Pharma Industria Farmaceutica Limitada subsidiary Sale of goods or services Not Applicable 4,123.60 2,498.50 1,483.80
469 Eugia Pharma Specialities Ltd Aurobindo Pharma Colombia S A S subsidiary Sale of goods or services Not Applicable 145.90 64.20 151.00
470 Eugia Pharma Specialities Ltd Eugia Pharma Colombia S.A.S. subsidiary Sale of goods or services Not Applicable 1,890.20 1,390.70 2,001.90
471 Eugia Pharma Specialities Ltd Aurovida Farmaceutica SA DE CV subsidiary Sale of goods or services Not Applicable 1,459.00 7,619.00 5,300.80
472 Eugia Pharma Specialities Ltd Aurogen South Africa (PTY) Ltd subsidiary Sale of goods or services Not Applicable 3,053.40 851.30 2,299.00
473 Eugia Pharma Specialities Ltd Aurobindo Pharma USA Inc. subsidiary Sale of goods or services Not Applicable 26,902.30 20,238.70 15,197.70
474 Eugia Pharma Specialities Ltd Auro Health LLC subsidiary Sale of goods or services Not Applicable 248.40 483.00 250.10
475 Eugia Pharma Specialities Ltd Eugia US LLC subsidiary Sale of goods or services Not Applicable 79,839.20 15,346.90 35,247.40
476 Eugia Pharma Specialities Ltd Milpharm Limited subsidiary Sale of goods or services Not Applicable 664.30 875.50 666.00
477 Eugia Pharma Specialities Ltd Eugia Steriles Private Limited subsidiary Sale of goods or services Not Applicable 128.40 19.80 147.50
478 Eugia Pharma Specialities Ltd Eugia Steriles Private Limited subsidiary Interest received Not Applicable 596.00 948.70 0.00
479 Eugia Pharma Specialities Ltd Eugia Steriles Private Limited subsidiary Loan Not Applicable 0.00 14,900.00 16,352.90
480 Eugia Pharma Specialities Ltd GLS Pharma Limited subsidiary Sale of goods or services Not Applicable 15.30 15.30 15.30
481 CuraTeQ Biologics B.V., Netherlands CuraTeQ Biologics s.r.o. subsidiary Interest received Not Applicable 19.70 3.50 23.00
482 CuraTeQ Biologics B.V., Netherlands CuraTeQ Biologics s.r.o. subsidiary Loan Not Applicable 0.00 1,090.00 838.20
483 CuraTeQ Biologics B.V., Netherlands APL Swift Services (Malta) Ltd subsidiary Loan Not Applicable 0.00 3,269.90 0.00
484 CuraTeQ Biologics B.V., Netherlands APL Swift Services (Malta) Ltd subsidiary Interest received Not Applicable 26.20 3.90 0.10
485 Auroactive Pharma Private limited APL Healthcare Limited subsidiary Sale of goods or services Not Applicable 1,811.40 449.80 1,038.20
486 Auroactive Pharma Private limited TheraNyM Biologics Private Limited subsidiary Sale of goods or services Not Applicable 0.80 0.00 0.00
487 Auroactive Pharma Private limited TheraNyM Biologics Private Limited subsidiary Sale of fixed assets Not Applicable 10.00 0.00 0.00
488 Auroactive Pharma Private limited Eugia Steriles Private Limited subsidiary Sale of fixed assets Not Applicable 0.20 0.00 0.20
489 Auroactive Pharma Private limited Lyfius Pharma Private Limited subsidiary Sale of fixed assets Not Applicable 0.00 66.80 66.80
490 Auroactive Pharma Private limited Qule Pharma Private Limited subsidiary Sale of fixed assets Not Applicable 22.60 113.30 2.30
491 A1 Biochem Labs (India) Private Limited A1 Biochem USA Inc subsidiary Loan Not Applicable 0.00 0.00 11,737.20
492 A1 Biochem Labs (India) Private Limited A1 Biochem USA Inc subsidiary Investment Not Applicable 2,874.50 0.00 0.00
493 Aurolife Pharma LLC Eugia US Manufacturing LLC subsidiary Any other transaction Trade Receivable Not Applicable 0.00 272.50 0.00
494 PT Aurogen Pharma Indonesia PT Auro Pharm Indonesia subsidiary Any other transaction Rent received Not Applicable 28.40 0.00 0.00
495 PT Aurogen Pharma Indonesia PT Auro Pharm Indonesia subsidiary Investment Not Applicable 530.00 0.00 0.00
496 Eugia Pharma Specialities Ltd Eugia Steriles Private Limited subsidiary Investment Not Applicable 17,700.00 0.00 0.00
497 CuraTeQ Biologics B.V., Netherlands CuraTeQ Biologics (Malta) Limited subsidiary Investment Not Applicable 5,491.20 0.00 0.00
498 Helix Healthcare B.V. Aurobindo Pharma (Malaysia) SDN. BHD. subsidiary Investment Not Applicable 76.10 0.00 0.00
499 Helix Healthcare B.V. Aurobindo Pharma Philippines Inc. subsidiary Investment Not Applicable 185.10 0.00 0.00
500 Agile Pharma B.V. Ace Laboratories Limited subsidiary Investment Not Applicable 191.60 0.00 0.00
501 Agile Pharma B.V. Arrow Pharma Production SAS subsidiary Investment Not Applicable 10,897.30 0.00 0.00
502 Aurobindo Pharma USA Inc. AuroLogistics LLC subsidiary Sale of goods or services Not Applicable 2,047.10 0.00 0.00
503 Aurobindo Pharma USA Inc. Auro Health LLC subsidiary Sale of goods or services Not Applicable 16.60 0.00 0.00
504 Aurobindo Pharma USA Inc. Auro Health LLC subsidiary Loan Not Applicable 0.00 26,701.00 20,272.10
505 Aurolife Pharma LLC Aurobindo Pharma USA Inc. subsidiary Sale of goods or services Not Applicable 0.00 1,582.30 0.00
506 Aurolife Pharma LLC Aurobindo Pharma USA Inc. subsidiary Any other transaction Rent received Not Applicable 168.20 0.00 0.00
507 Aurolife Pharma LLC Auro Health LLC subsidiary Sale of goods or services Not Applicable 10.30 0.00 10.30
508 Auro Health LLC Aurobindo Pharma USA Inc. subsidiary Sale of goods or services Not Applicable 1,703.10 1,079.10 0.00
509 Auro Health LLC Vespyr Brands LLC subsidiary Loan Not Applicable 0.00 52,505.20 53,053.50
510 Auro Health LLC Vespyr Brands LLC subsidiary Any other transaction Trade Receivable Not Applicable 0.00 0.00 43.00
511 AuroLogistics LLC Aurobindo Pharma USA Inc. subsidiary Sale of goods or services Not Applicable 13,794.80 0.00 0.00
512 AuroLogistics LLC Auro Health LLC subsidiary Sale of goods or services Not Applicable 2,349.10 0.00 0.00
513 AuroLogistics LLC Vespyr Brands LLC subsidiary Sale of goods or services Not Applicable 54.20 0.00 0.00
514 Auro Packaging LLC Auro Health LLC subsidiary Sale of goods or services Not Applicable 530.70 0.00 0.00
515 Auro Packaging LLC Vespyr Brands LLC subsidiary Sale of goods or services Not Applicable 3.40 0.00 0.00
516 Eugia SEZ Private Limited Aurobindo Pharma Foundation subsidiary Any other transaction Contribution towards CSR activities Not Applicable 54.00 0.00 0.00
517 APL Healthcare Limited Aurobindo Pharma Foundation subsidiary Any other transaction Contribution towards CSR activities Not Applicable 900.00 0.00 0.00
518 Eugia Pharma Specialities Ltd Aurobindo Pharma Foundation subsidiary Any other transaction Contribution towards CSR activities Not Applicable 500.00 0.00 0.00
519 Aurobindo Pharma USA Inc. Lannett Company LLC subsidiary Sale of fixed assets Not Applicable 5,702.80 0.00 5,749.50
520 Aurobindo Pharma USA Inc. Lannett Company LLC subsidiary Interest received Not Applicable 2,760.80 0.00 2,783.40
521 Aurobindo Pharma USA Inc. Lannett Company LLC subsidiary Loan Not Applicable 0.00 0.00 2,31,149.30
522 Aurobindo Pharma USA Inc. Lannett Company LLC subsidiary Investment Not Applicable 473.30 0.00 0.00
523 Aurobindo Pharma USA Inc. Lannett Company LLC subsidiary Any other transaction Reimbursement of expenses received Not Applicable 1,003.90 0.00 0.00
524 Aurobindo Pharma USA Inc. Aurolife Pharma LLC subsidiary Any other transaction Other Receivable Not Applicable 0.00 0.00 1,65,126.80
525 Aurobindo Pharma USA Inc. Auro Vaccines LLC subsidiary Any other transaction Other Receivable Not Applicable 0.00 0.00 46,755.10
526 Aurobindo Pharma USA Inc. AuroLogistics LLC subsidiary Any other transaction Other Receivable Not Applicable 0.00 0.00 5,020.20
527 Aurobindo Pharma USA Inc. Auro Packaging LLC subsidiary Any other transaction Other Receivable Not Applicable 0.00 0.00 17,169.20
528 Auro Health LLC Aurobindo Pharma USA Inc. subsidiary Any other transaction Other Receivable Not Applicable 0.00 0.00 1,519.50
529 Vespyr Brands LLC Aurobindo Pharma USA Inc. subsidiary Any other transaction Other Receivable Not Applicable 0.00 0.00 714.60
530 Auro AR LLC Aurobindo Pharma USA Inc. subsidiary Any other transaction Other Receivable Not Applicable 0.00 0.00 95.80
531 Acrotech Biopharma Inc. Aurobindo Pharma USA Inc. subsidiary Any other transaction Other Receivable Not Applicable 0.00 0.00 73,355.10
532 APL Healthcare Limited Alcedo Pharmachem Private Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 4,967.60 537.80 552.70
533 APL Healthcare Limited East Pharma Technologies Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 270.90 107.40 34.50
534 APL Healthcare Limited Gelcaps�Industries Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 2,738.80 868.00 1,427.60
535 APL Healthcare Limited Orem Access Bio Inc Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 1,112.90 268.00 236.10
536 APL Healthcare Limited Pranit Packaging Private Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 0.00 0.00 0.00
537 APL Healthcare Limited Sri Sai Packaging Works Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 307.70 58.20 49.70
538 APL Healthcare Limited Valucor Packaging Private Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 1,662.50 234.00 268.00
539 APL Healthcare Limited Garuda Renewables Private Limited Associates Investment Not Applicable 148.50 0.00 0.00
540 CuraTeQ Biologics Private Limited Axis Clinicals Ltd Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable (564.30) 2,623.30 0.00
541 CuraTeQ Biologics Private Limited Axis Clinicals Ltd Enterprises over which key managerial personnel or their relatives exercise significant influence Advance Not Applicable 0.00 0.00 1,308.80
542 CuraTeQ Biologics Private Limited East Pharma Technologies Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 33.90 0.00 13.60
543 CuraTeQ Biologics Private Limited Sri Sai Packaging Works Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 3.10 0.00 0.00
544 CuraTeQ Biologics Private Limited Auro Enterprises (India) Private Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 33.50 0.00 0.00
545 CuraTeQ Biologics Private Limited Auro Enterprises (India) Private Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Advance Not Applicable 0.00 0.00 0.50
546 CuraTeQ Biologics Private Limited Valucor Packaging Private Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 2.90 0.00 0.00
547 Eugia Steriles Private Limited Garuda Renewables Private Limited Associates Investment Not Applicable 110.00 0.00 0.00
548 Eugia Steriles Private Limited Pravesha Industries Private Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 11.40 0.80 9.10
549 Eugia Steriles Private Limited Valucor Packaging Private Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 10.90 2.50 5.90
550 Eugia Steriles Private Limited Auro Enterprises (India) Private Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 31.50 3.30 6.50
551 Eugia Steriles Private Limited Sri Sai Packaging Works Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 2.70 0.00 0.40
552 Eugia Steriles Private Limited East Pharma Technologies Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 66.20 13.20 16.20
553 Lyfius Pharma Private Limited Kakinada SEZ Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Advance Not Applicable 0.00 676.20 676.20
554 Lyfius Pharma Private Limited Sri Sai Packaging Works Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 86.80 43.00 0.00
555 Lyfius Pharma Private Limited East Pharma Technologies Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 0.00 0.60 0.00
556 Lyfius Pharma Private Limited Auro Enterprises (India) Private Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 6,588.00 307.20 6,117.20
557 Lyfius Pharma Private Limited Shreas industries limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 1,438.10 488.30 52.50
558 Lyfius Pharma Private Limited Garuda Renewables Private Limited Associates Investment Not Applicable 770.00 0.00 0.00
559 Lyfius Pharma Private Limited Kakinada Gateway Port Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Advance Not Applicable 0.00 0.10 0.10
560 Qule Pharma Private Limited Kakinada SEZ Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 197.00 0.00 0.00
561 Qule Pharma Private Limited Kakinada SEZ Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Advance Not Applicable 0.00 184.90 179.90
562 Qule Pharma Private Limited Shreas Industries Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 497.80 64.00 71.10
563 Qule Pharma Private Limited Sri Sai Packaging Works Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 32.30 0.00 0.00
564 Qule Pharma Private Limited Valucor Packaging Private Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 0.20 0.00 0.00
565 Qule Pharma Private Limited Pranit Packaging Private Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 0.00 0.10 0.00
566 Auroactive Pharma Private limited Sri Sai Packaging Works Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 75.30 23.40 21.70
567 Auroactive Pharma Private limited Valucor Packaging Private Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 0.20 0.00 0.20
568 Auroactive Pharma Private limited Auro Enterprises (India) Private Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 446.50 17.00 0.00
569 Auroactive Pharma Private limited Shreas Industries Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 1,217.50 201.90 328.50
570 Auroactive Pharma Private limited Shreas Industries Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of fixed assets Not Applicable 17.60 0.00 0.00
571 Auroactive Pharma Private limited Garuda Renewables Private Limited Associates Investment Not Applicable 110.00 0.00 0.00
572 Eugia SEZ Private Limited East Pharma Technologies Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 155.50 32.50 29.30
573 Eugia SEZ Private Limited Pravesha Industries Private Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 52.80 88.00 16.20
574 Eugia SEZ Private Limited Valucor Packaging Private Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 53.30 17.30 13.60
575 Eugia SEZ Private Limited Sri Sai Packaging Works Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 12.10 0.00 3.90
576 Eugia Pharma Specialities Ltd East Pharma Technologies Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 756.90 179.70 187.70
577 Eugia Pharma Specialities Ltd Orem Access Bio Inc Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 2.60 3.50 0.30
578 Eugia Pharma Specialities Ltd Pravesha Industries Private Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 784.00 500.90 350.50
579 Eugia Pharma Specialities Ltd Valucor Packaging Private Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 214.70 63.20 35.60
580 Eugia Pharma Specialities Ltd Sri Sai Packaging Works Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 64.00 3.30 13.60
581 Eugia Pharma Specialities Ltd Auro Enterprises (India) Private Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 466.20 0.00 90.20
582 Eugia Pharma Specialities Ltd Auro Enterprises (India) Private Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Advance Not Applicable 0.00 173.70 0.00
583 Eugia Pharma Specialities Ltd Trident Chemphar Limited Enterprises over which key managerial personnel or their relatives exercise significant influence Any other transaction Trade Payable Not Applicable 0.00 3.50 3.50
584 Eugia Pharma Specialities Ltd Axis Clinicals Ltd Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 166.80 41.30 0.00
585 Acrotech Biopharma Inc. Axis Clinicals LLC USA Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 277.30 265.50 8.10
586 Aurobindo Pharma USA Inc. Axis Clinicals LLC USA Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 50.70 0.00 0.00
587 Aurobindo Pharma USA Inc. Axis Clinicals Ltd Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 652.40 127.10 199.40
588 Aurobindo Pharma USA Inc. Luoxin Aurovitas Pharma (Chengdu) Co. Ltd. Joint Venture Purchase of goods or services Not Applicable 1,592.00 210.50 0.00
589 Aurobindo Pharma USA Inc. Mr.P.V. Ramprasad Reddy, Promoter Director Key managerial personnel Remuneration Not Applicable 202.20 0.00 0.00
590 Auro Peptides Ltd Sri Sai Packaging Works Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 1.80 0.00 1.80
591 Auropharm Limited Transaction Square LLP Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 71.30 0.00 0.00
592 Auro Pharma Inc. Axis Clinicals Ltd Enterprises over which key managerial personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 585.80 0.00 0.00
593 Helix Healthcare B.V. Luoxin Aurovitas Pharma (Chengdu) Co. Ltd. Joint Venture Investment Not Applicable 1,931.00 0.00 0.00
594 APITORIA PHARMA PRIVATE LIMITED ALL PHARMA (SHANGHAI) TRADING CO.,LTD subsidiary Purchase of goods or services Not Applicable 84.90 69.60 29.50
595 APITORIA PHARMA PRIVATE LIMITED APL HEALTH CARE LIMITED subsidiary Purchase of goods or services Not Applicable 891.00 40.10 78.30
596 APITORIA PHARMA PRIVATE LIMITED ARROW GENERIQUES subsidiary Purchase of goods or services Not Applicable 0.00 0.00 0.00
597 APITORIA PHARMA PRIVATE LIMITED Auro Infra Private Limited (formerly known as Aurobindo Realty & Infrastructure Pvt. Ltd.) Enterprises over which key management personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 0.00 0.00 0.00
598 APITORIA PHARMA PRIVATE LIMITED AUROACTIVE PHARMA PRIVATE LIMITED subsidiary Purchase of goods or services Not Applicable 104.50 69.00 14.70
599 APITORIA PHARMA PRIVATE LIMITED AUROACTIVE PHARMA PRIVATE LIMITED subsidiary Any other transaction Purchase of Assets Not Applicable 21.80 0.00 18.90
600 APITORIA PHARMA PRIVATE LIMITED AUROPRO SOFT SYSTEMS PVT. LTD Enterprises over which key management personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 322.10 0.00 0.00
601 APITORIA PHARMA PRIVATE LIMITED AUROBINDO PHARMA JAPAN KK subsidiary Purchase of goods or services Not Applicable 0.00 0.00 0.00
602 APITORIA PHARMA PRIVATE LIMITED EUGIA PHARMA SPECIALITIES LIMITED subsidiary Purchase of goods or services Not Applicable 204.10 18.10 21.00
603 APITORIA PHARMA PRIVATE LIMITED AUROBINDO PHARMA PRODUTOS FARMACEUTICOS LTDA subsidiary Purchase of goods or services Not Applicable 0.00 13.90 0.00
604 APITORIA PHARMA PRIVATE LIMITED Eugia SEZ Pvt.Ltd., (Wytells Pharma Pvt.Ltd.,) subsidiary Purchase of goods or services Not Applicable 96.20 0.00 0.00
605 APITORIA PHARMA PRIVATE LIMITED NVNR (Ramannapet I) Power Plant Private Limited, India Associate Company Purchase of goods or services Not Applicable 309.40 41.80 15.80
606 APITORIA PHARMA PRIVATE LIMITED NVNR (Ramannapet II) Power Plant Private Limited, India Associate Company Purchase of goods or services Not Applicable 114.80 9.40 68.70
607 APITORIA PHARMA PRIVATE LIMITED Orem Access Bio Inc, India Enterprises over which key management personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 0.00 0.00 0.00
608 APITORIA PHARMA PRIVATE LIMITED Pranit Packaging Private Limited, India Enterprises over which key management personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 0.00 0.00 0.00
609 APITORIA PHARMA PRIVATE LIMITED Sri Sai Packaging, India Enterprises over which key management personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 944.20 158.20 259.80
610 APITORIA PHARMA PRIVATE LIMITED LYFIUS PHARMA PRIVATE LIMITED subsidiary Purchase of goods or services Not Applicable 72.90 7.50 0.00
611 APITORIA PHARMA PRIVATE LIMITED LYFIUS PHARMA PRIVATE LIMITED subsidiary Purchase of fixed assets Not Applicable 1.70 0.00 0.00
612 APITORIA PHARMA PRIVATE LIMITED QULE PHARMA PRIVATE LIMITED subsidiary Purchase of goods or services Not Applicable 36,807.70 5,405.60 6,583.30
613 APITORIA PHARMA PRIVATE LIMITED QULE PHARMA PRIVATE LIMITED subsidiary Purchase of fixed assets Not Applicable 142.00 0.00 64.40
614 APITORIA PHARMA PRIVATE LIMITED Auro Enterprises (India) Private Limited Enterprises over which key management personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 10,018.90 (2,745.50) 1,866.70
615 APITORIA PHARMA PRIVATE LIMITED EAST PHARMA TECHNOLOGIES Enterprises over which key management personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 0.30 0.00 0.00
616 APITORIA PHARMA PRIVATE LIMITED SHREAS INDUSTRIES LIMITED Enterprises over which key management personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 5,747.80 1,001.20 1,660.90
617 APITORIA PHARMA PRIVATE LIMITED VALUCOR PACKAGING PRIVATE LIMITED Enterprises over which key management personnel or their relatives exercise significant influence Purchase of goods or services Not Applicable 73.20 27.70 39.10
618 APITORIA PHARMA PRIVATE LIMITED AGILE PHARMA BV subsidiary Sale of goods or services Not Applicable 433.80 44.00 260.60
619 APITORIA PHARMA PRIVATE LIMITED APL HEALTH CARE LIMITED subsidiary Sale of goods or services Not Applicable 67,925.20 26,094.00 32,577.10
620 APITORIA PHARMA PRIVATE LIMITED ARROW GENERIQUES subsidiary Sale of goods or services Not Applicable 33.00 0.00 32.70
621 APITORIA PHARMA PRIVATE LIMITED AURO PEPTIDES LIMITED subsidiary Sale of goods or services Not Applicable 20.80 8.20 14.10
622 APITORIA PHARMA PRIVATE LIMITED AUROACTIVE PHARMA PRIVATE LIMITED subsidiary Sale of goods or services Not Applicable 15.50 0.10 6.40
623 APITORIA PHARMA PRIVATE LIMITED AUROBINDO PHARMA (PTY) LTD subsidiary Sale of goods or services Not Applicable 3,152.80 2,437.30 2,913.30
624 APITORIA PHARMA PRIVATE LIMITED AUROBINDO PHARMA JAPAN KK subsidiary Sale of goods or services Not Applicable 1,072.30 19.70 365.40
625 APITORIA PHARMA PRIVATE LIMITED AUROBINDO PHARMA USA INC subsidiary Sale of goods or services Not Applicable 41.10 0.00 41.40
626 APITORIA PHARMA PRIVATE LIMITED AUROLIFE PHARMA LLC subsidiary Sale of goods or services Not Applicable 88.50 0.00 59.40
627 APITORIA PHARMA PRIVATE LIMITED AUROPHARM LIMITED subsidiary Sale of goods or services Not Applicable 415.40 0.00 195.60
628 APITORIA PHARMA PRIVATE LIMITED AUROVITAS PHARMA TAIZHOU CO. , LTD subsidiary Sale of goods or services Not Applicable 2,441.10 4,580.90 4,469.70
629 APITORIA PHARMA PRIVATE LIMITED EUGIA PHARMA SPECIALITIES LIMITED subsidiary Sale of goods or services Not Applicable 4,960.80 9,329.90 2,714.60
630 APITORIA PHARMA PRIVATE LIMITED Eugia SEZ Pvt.Ltd., (Wytells Pharma Pvt.Ltd.,) subsidiary Sale of goods or services Not Applicable 5,966.00 1,995.10 2,818.60
631 APITORIA PHARMA PRIVATE LIMITED Eugia Sterile Pvt.Ltd., (Auro Cure Pvt.Ltd.,) subsidiary Sale of goods or services Not Applicable 3.00 882.80 3.00
632 APITORIA PHARMA PRIVATE LIMITED GENERIS FARMACEUTICA SA subsidiary Sale of goods or services Not Applicable 449.00 160.30 169.40
633 APITORIA PHARMA PRIVATE LIMITED Giyaan Pharma Privated Limited, India Enterprises over which key management personnel or their relatives exercise significant influence Sale of goods or services Not Applicable 287.40 300.90 547.20
634 APITORIA PHARMA PRIVATE LIMITED LANNETT COMPANY, INC. subsidiary Sale of goods or services Not Applicable 33.30 0.00 34.10
635 APITORIA PHARMA PRIVATE LIMITED LYFIUS PHARMA PRIVATE LIMITED subsidiary Sale of goods or services Not Applicable 0.00 18.70 48.20
636 APITORIA PHARMA PRIVATE LIMITED QULE PHARMA PRIVATE LIMITED subsidiary Sale of goods or services Not Applicable 432.80 12.10 179.20
637 APITORIA PHARMA PRIVATE LIMITED SHREAS INDUSTRIES LIMITED Enterprises over which key management personnel or their relatives exercise significant influence Sale of goods or services Not Applicable 0.00 6.60 6.60
638 APITORIA PHARMA PRIVATE LIMITED Sri Sai Packaging, India Enterprises over which key management personnel or their relatives exercise significant influence Sale of goods or services Not Applicable 0.00 0.00 0.00
639 APITORIA PHARMA PRIVATE LIMITED AUROBINDO PHARMA PRODUTOS FARMACEUTICA LTDA subsidiary Sale of goods or services Not Applicable 0.00 0.00 0.00
640 APITORIA PHARMA PRIVATE LIMITED Aurolife Pharma LLC subsidiary Any other transaction Advances from Customers Not Applicable 0.00 20.80 0.00
641 APITORIA PHARMA PRIVATE LIMITED LYFIUS PHARMA PRIVATE LIMITED subsidiary Any other transaction Sale of PPE Not Applicable 0.40 0.00 0.00
642 APITORIA PHARMA PRIVATE LIMITED QULE PHARMA PRIVATE LIMITED subsidiary Any other transaction Sale of PPE Not Applicable 6.70 0.00 0.10
643 APITORIA PHARMA PRIVATE LIMITED AUROACTIVE PHARMA PRIVATE LIMITED subsidiary Any other transaction Sale of PPE Not Applicable 2.10 0.00 2.10
644 APITORIA PHARMA PRIVATE LIMITED AUROBINDO PHARMA FOUNDATION subsidiary Any other transaction Sale of PPE Not Applicable 0.00 0.00 0.00
645 APITORIA PHARMA PRIVATE LIMITED GLS PHARMA LIMITED subsidiary Any other transaction Sale of PPE Not Applicable 18.70 0.00 18.70
646 APITORIA PHARMA PRIVATE LIMITED AUROBINDO PHARMA FOUNDATION subsidiary Any other transaction CSR Contribution Not Applicable 300.00 0.00 0.00
647 APITORIA PHARMA PRIVATE LIMITED AURO PEPTIDES LIMITED subsidiary Any other transaction Reimbursement of Expenses Not Applicable 3.00 0.00 0.00
648 APITORIA PHARMA PRIVATE LIMITED AUROBINDO PHARMA PRODUTOS FARMACEUTICA LTDA subsidiary Any other transaction Reimbursement of Expenses Not Applicable 0.00 0.00 0.00
649 APITORIA PHARMA PRIVATE LIMITED AUROBINDO PHARMA (ITALIA) SRL subsidiary Any other transaction Reimbursement of Expenses Not Applicable 11.20 10.40 3.50
650 APITORIA PHARMA PRIVATE LIMITED EUGIA PHARMA SPECIALITIES LIMITED subsidiary Any other transaction Reimbursement of Expenses Not Applicable 13.10 0.00 0.00
651 APITORIA PHARMA PRIVATE LIMITED A1 BIOCHEM LABS (INDIA) PRIVATE LIMITED subsidiary Investment Not Applicable 13,239.00 0.00 0.00
652 APITORIA PHARMA PRIVATE LIMITED AUROBINDO PHARMA PRODUTOS FARMACEUTICA LTDA subsidiary Any other transaction Sales Commission Not Applicable 132.20 0.00 16.90
653 APITORIA PHARMA PRIVATE LIMITED AUROBINDO PHARMA JAPAN KK subsidiary Any other transaction Sales Commission Not Applicable 254.50 0.00 48.60
Total value of transaction during the reporting period 16,77,153.20